Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016701	p-glu/2h	mmol/l (mmol/l)	1307	1817	0.00%
3016701	p-glukr2h	mmol/l (mmol/l)	1275	1595	0.00%
3016701	p-gluk-2h	mmol/l (mmol/l)	653	896	0.00%
3016701	glukr2h	mmol/l (—)	505	779	100.00%	Distribution not available
3016701	gluk120min	— (—)	332	346	100.00%	Distribution not available
3016701	p-gluk-2t	mmol/l (mmol/l)	315	460	0.00%
3016701	fp-glukoosi(gluk.ras2h)	mmol/l (mmol/l)	214	225	0.00%
3016701	gluk2h	mmol/l (—)	199	280	100.00%	Distribution not available
3016701	p-gluk/2h	mmol/l (mmol/l)	164	180	0.00%
3016701	p-gluk-2h	— (—)	160	260	100.00%	Distribution not available
3016701	fp-gluk-2	mmol/l (mmol/l)	135	168	0.00%
3016701	glukras120	mmol/l (—)	119	153	100.00%	Distribution not available
3016701	glukr-2h	mmol/l (—)	113	144	100.00%	Distribution not available
3016701	p-gluk2h	— (—)	106	125	100.00%	Distribution not available
3016701	fp-gluk-2h	mmol/l (mmol/l)	96	109	0.00%
3016701	glukoosi120min	mmol/l (—)	94	98	100.00%	Distribution not available
3016701	p-gluk2h	mmol/l (mmol/l)	77	90	0.00%
3016701	glukoosikoe,2hnäyte	mmol/l (—)	59	62	100.00%	Distribution not available
3016701	p-glukr2h	— (—)	56	58	100.00%	Distribution not available
3016701	p-gluk-2t	— (—)	54	59	100.00%	Distribution not available
3016701	p-glukoosi2h	mmol/l (mmol/l)	46	53	0.00%
3016701	fp-glukr2h	mmol/l (mmol/l)	42	45	0.00%
3016701	p-gluk-2	mmol/l (mmol/l)	40	56	0.00%
3016701	p-glu/2h	— (—)	34	34	100.00%	Distribution not available
3016701	p-glukgr2	mmol/l (mmol/l)	31	33	0.00%
3016701	p-glukoosi,2h	mmol/l (mmol/l)	25	31	0.00%
3016701	p-gluk(2	mmol/l (mmol/l)	14	18	0.00%
3016701	p-gluk2t	mmol/l (mmol/l)	13	13	0.00%	Distribution not available
3016701	s-glukoosi,2hnäyte	mmol/l (mmol/l)	12	12	0.00%
3016701	s-glukr2h	mmol/l (mmol/l)	11	11	0.00%	Distribution not available
3016701	fp-gluk-2	— (—)	9	9	100.00%	Distribution not available
3016701	p-glukoosi,2hnäyte	mmol/l (mmol/l)	9	9	0.00%	Distribution not available
3016701	p-gluk/2h	— (—)	9	10	100.00%	Distribution not available
3016701	p-gluk(2)	mmol/l (mmol/l)	5	5	0.00%	Distribution not available
3016701	p-gluk-2	— (—)	5	5	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Contact with and exposure to communicable diseases

808

2412

3.45

219.83

1.5

6.47

6.66

mmol/l

1.24

789

2177

Persons with potential health hazards related to communicable diseases

859

2829

3.10

196.32

1.5

1.4

6.59

6.75

mmol/l

1.00

839

2539

Postpartum care and examination

413

458

5.99

187.12

1.6

1.3

6.38

7.12

mmol/l

4.81

397

404

Diabetes mellitus in pregnancy

773

1717

2.97

146.12

1.9

1.3

6.95

6.43

mmol/l

6.80

706

1576

Other maternal disorders predominantly related to pregnancy

904

2538

2.27

101.23

1.7

1.3

6.89

6.74

mmol/l

1.00

831

2306

Single delivery by caesarean section

325

446

4.30

100.98

1.6

1.2

6.53

7.59

mmol/l

7.24

298

410

Single delivery by forceps and vacuum extractor

263

346

4.71

92.71

1.7

1.2

6.34

7.55

mmol/l

9.18

244

326

Outcome of delivery

330

564

3.72

87.84

1.5

1.3

6.47

7.15

mmol/l

3.38

323

497

Maternal care for other known or suspected fetal problems

486

1132

2.79

82.68

1.8

1.4

6.40

6.68

mmol/l

1.86

449

1032

Delivery, wide proxy

388

639

3.28

82.21

1.6

1.2

6.59

7.75

mmol/l

10.96

347

547

Delivery

456

833

2.93

80.85

1.6

1.2

6.57

7.74

mmol/l

14.10

404

725

Gestational diabetes (for exclusion)

748

2402

2.21

80.48

1.8

1.4

7.01

6.43

mmol/l

8.63

689

2215

Single spontaneous delivery

450

833

2.90

78.62

1.6

1.2

6.61

7.74

mmol/l

12.59

399

725

Pregnancy, childbirth and the puerperium

329

510

3.42

73.95

1.6

1.2

6.70

7.71

mmol/l

6.74

292

433

Type 2 diabetes, definitions combined, including avohilmo

1137

3639

1.83

71.37

1.4

1.3

9.29

6.39

mmol/l

110.18

1007

3230

Non-invasive ventilation

356

1195

2.71

63.43

1.3

7.15

6.37

mmol/l

5.45

325

1061

False labour

511

1386

2.34

61.55

1.6

1.4

6.39

6.79

mmol/l

3.28

471

1255

Prolonged pregnancy

309

991

2.80

57.90

1.7

1.4

6.09

6.66

mmol/l

3.63

289

904

Other nutritional deficiencies

860

4498

1.82

57.62

1.6

1.3

7.34

6.90

mmol/l

4.95

762

4036

Abnormal findings on antenatal screening of mother

220

690

3.32

56.47

1.9

1.4

6.30

6.27

mmol/l

0.07

196

640

Obesity due to excess calories

645

3309

1.97

56.08

1.6

1.3

7.40

6.89

mmol/l

4.52

570

2992

Other symptoms and signs involving the urinary system

163

427

3.92

54.71

1.3

7.55

7.49

mmol/l

0.08

158

365

Endocrine, nutritional and metabolic diseases

1016

2994

1.73

51.17

1.4

1.3

7.63

6.25

mmol/l

35.16

913

2695

Sleep apnoea, including avohilmo

1023

3744

1.70

51.02

1.3

7.47

7.17

mmol/l

2.38

908

3302

Type 2 diabetes, strict (exclude DM1)

1060

3721

1.68

50.10

1.4

1.3

9.42

6.46

mmol/l

105.97

936

3301

Type 2 diabetes, definitions combined

1058

3713

1.68

50.05

1.4

1.3

9.43

6.46

mmol/l

105.82

934

3293

Antenatal screening

341

752

2.59

49.45

1.5

1.3

6.39

7.18

mmol/l

5.89

311

665

Obesity and other hyperalimentation

804

4421

1.77

49.44

1.6

1.3

7.40

6.89

mmol/l

5.76

713

3968

Obesity

801

4410

1.77

49.30

1.6

1.3

7.40

6.89

mmol/l

5.76

710

3961

Maternal care related to the fetus and amniotic cavity and possible delivery problems

622

1866

1.98

49.11

1.6

1.3

6.64

6.96

mmol/l

2.26

572

1683

Sleep apnoea

936

3558

1.71

48.27

1.3

7.58

7.26

mmol/l

2.38

826

3124

Other obstetric conditions, not elsewhere classified

608

2051

1.92

44.30

1.7

1.5

6.33

6.53

mmol/l

1.63

573

1881

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

598

2015

1.92

43.50

1.7

1.5

6.33

6.51

mmol/l

1.35

564

1848

Continuous positive airway pressure

218

653

2.85

42.71

1.3

1.2

7.67

6.53

mmol/l

5.78

179

559

Maternal care for known or suspected abnormality of pelvic organs

393

1261

2.16

40.22

1.7

1.3

6.72

6.84

mmol/l

0.47

364

1136

Supervision of high-risk pregnancy

288

714

2.47

38.84

1.7

1.3

6.63

7.18

mmol/l

2.92

272

631

Insulin, intermediate and long-acting

3038

0.25

38.72

1.5

1.3

11.10

7.31

mmol/l

3.62

2646

Maternal care for other conditions predominantly related to pregnancy

333

1563

2.12

35.39

1.7

1.3

6.63

6.50

mmol/l

0.48

301

1428

Type 2 diabetes

1045

3973

1.55

35.12

1.4

1.3

9.46

6.43

mmol/l

102.35

922

3537

Supervision of normal pregnancy

296

735

2.33

35.06

1.6

1.3

6.20

7.19

mmol/l

9.81

275

650

Insulin, fast-acting or short human

2161

0.16

33.42

1.2

1.3

12.49

7.20

mmol/l

3.23

1900

Insulin, fast-acting

2154

0.17

33.28

1.2

1.3

12.49

7.18

mmol/l

3.25

1897

Insulin, combination of fast acting with intermediate-acting or long-acting

130

3328

0.35

32.84

1.8

1.3

9.80

7.27

mmol/l

4.70

101

2901

Episodal and paroxysmal disorders

1190

4088

1.49

32.72

1.3

1.4

7.15

6.97

mmol/l

1.27

1077

3630

Maternal care for known or suspected malpresentation of fetus

298

1012

2.17

31.56

1.7

1.4

6.29

6.67

mmol/l

2.48

280

921

Long labour

369

1634

1.96

30.91

1.7

1.4

6.69

6.67

mmol/l

0.03

333

1481

Complications of labour and delivery

715

2442

1.64

30.54

1.5

1.4

6.94

6.88

mmol/l

0.21

656

2195

Acute upper respiratory infections of multiple and unspecified sites

843

4046

1.55

30.42

1.4

1.3

6.94

7.01

mmol/l

0.33

775

3594

Other (not insulin) diabetes medications

986

3886

1.51

30.33

1.4

1.3

9.55

6.53

mmol/l

98.51

860

3447

Labour and delivery complicated by fetal stress [distress]

402

1393

1.92

29.89

1.6

1.5

6.35

6.52

mmol/l

0.88

374

1273

Polyhydramnios

102

305

3.47

28.51

1.8

1.4

6.55

7.00

mmol/l

1.30

274

Insulin medication

130

2831

0.38

27.59

1.8

1.3

9.80

6.58

mmol/l

6.90

101

2485

Persons encountering health services in circumstances related to reproduction

553

2268

1.65

25.49

1.4

1.2

6.77

7.35

mmol/l

5.24

508

2001

Diabetes, varying definitions

1043

4264

1.44

25.19

1.4

1.3

9.42

6.40

mmol/l

100.43

923

3809

Other special examinations and investigations of persons without complaint or reported diagnosis

744

2438

1.55

25.07

1.3

7.22

6.94

mmol/l

1.75

661

2173

Diabetes mellitus

1046

4298

1.43

24.20

1.4

1.3

9.43

6.39

mmol/l

99.25

926

3840

Biguanides

909

3813

1.46

23.75

1.4

1.3

9.64

6.56

mmol/l

91.74

787

3381

Obstructed labour due to malposition and malpresentation of fetus

326

1658

1.86

23.75

1.6

1.4

6.57

6.69

mmol/l

0.42

303

1499

Hypertension

750

2800

1.52

23.47

1.2

1.3

7.82

6.98

mmol/l

8.99

674

2475

Hypertensive diseases

750

2803

1.52

23.38

1.2

1.3

7.82

6.98

mmol/l

8.99

674

2478

Premature rupture of membranes

301

1132

1.93

23.38

1.6

1.4

6.50

6.72

mmol/l

1.09

287

1020

Gestational [pregnancy-induced] hypertension

381

2194

1.76

23.20

1.6

1.5

6.93

6.68

mmol/l

1.12

344

2015

Hypertension, essential

726

2708

1.53

23.15

1.2

7.87

7.01

mmol/l

8.60

656

2390

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

581

3233

1.58

22.99

1.5

1.4

6.92

6.78

mmol/l

0.62

530

2950

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1108

4311

1.40

22.81

1.4

1.3

7.23

7.05

mmol/l

1.18

1011

3783

Persons encountering health services in other circumstances, wide

1159

4312

1.39

22.34

1.3

7.21

7.05

mmol/l

1.00

1058

3783

Pregnancy examination and test

187

518

2.27

21.63

1.6

1.3

6.60

7.06

mmol/l

1.51

170

454

Additional codes for the location of defect, injury or illness

263

3.24

21.14

1.5

1.4

6.95

7.30

mmol/l

0.39

229

Acute upper respiratory infections

1014

4485

1.40

21.08

1.4

1.3

7.12

7.08

mmol/l

0.22

922

3952

Sleep disorders (combined)

1129

4317

1.38

20.86

1.3

1.4

7.25

6.97

mmol/l

2.44

1020

3827

Diabetic retinopathy, excluding more controls

1092

0.30

20.73

1.2

1.4

9.75

9.35

mmol/l

0.38

963

Disease of hard tissues of teeth, NOS

513

1689

1.60

19.79

1.3

1.2

7.29

7.27

mmol/l

0.05

458

1455

Caries of dentine, including avohilmo

704

2431

1.49

19.56

1.3

7.31

7.11

mmol/l

0.83

628

2129

Neurological diseases

941

3377

1.41

19.45

1.3

1.4

7.01

6.92

mmol/l

0.48

850

2995

Hypertensive diseases (excluding secondary)

548

2055

1.56

19.45

1.2

1.3

7.96

6.90

mmol/l

10.01

498

1819

Other disorders of amniotic fluid and membranes

196

949

2.05

19.22

1.7

1.4

6.45

6.69

mmol/l

1.00

188

860

Other diseases of hard tissues of teeth

516

1700

1.58

18.90

1.3

1.2

7.29

7.28

mmol/l

0.02

461

1465

Pregnancy hypertension

529

3112

1.54

18.85

1.5

1.4

6.88

6.78

mmol/l

0.40

482

2840

Any death

152

2278

0.48

18.78

1.1

1.2

8.07

7.62

mmol/l

1.05

138

1931

Diabetic retinopathy

1277

0.36

18.01

1.2

1.3

10.27

9.47

mmol/l

0.83

1113

General examination and investigation of persons without complaint and reported diagnosis

681

2438

1.46

17.74

1.4

1.3

7.14

6.94

mmol/l

1.04

630

2173

Perineal laceration during delivery

268

1257

1.81

17.69

1.6

1.5

6.21

6.49

mmol/l

1.69

253

1149

Bronchitis

1049

4921

1.35

17.53

1.4

1.3

7.05

7.04

mmol/l

0.03

964

4349

Disorders of lipoprotein metabolism and other lipidaemias

678

2912

1.45

17.26

1.3

1.2

7.79

7.34

mmol/l

2.76

586

2541

Diabetes medication

1002

4400

1.36

17.23

1.4

1.3

9.54

6.46

mmol/l

97.71

882

3931

Dental caries, including avohilmo

627

2191

1.47

16.63

1.3

7.36

7.15

mmol/l

0.88

560

1904

Care involving use of rehabilitation procedures

583

3698

1.46

16.34

1.3

7.47

7.16

mmol/l

1.57

485

3283

Obesity related asthma

319

1991

1.61

14.56

1.3

7.58

7.25

mmol/l

1.29

282

1760

Presence of other devices

179

946

1.90

14.51

1.3

1.2

8.05

7.61

mmol/l

0.92

166

791

Postpartum haemorrhage

327

1722

1.61

14.47

1.6

1.4

6.32

6.67

mmol/l

2.76

309

1561

Statin medication

617

2444

1.43

14.30

1.2

1.3

7.82

6.73

mmol/l

13.60

554

2145

Dental operations

488

1681

1.50

14.29

1.3

1.2

7.47

7.33

mmol/l

0.41

437

1464

Parasetamol

818

3053

1.36

14.26

1.3

1.4

6.96

6.90

mmol/l

0.27

739

2703

Diseases of pulp and periapical tissues, including avohilmo

1020

4049

1.31

13.65

1.4

1.3

7.22

6.96

mmol/l

2.00

901

3605

Symptoms and signs involving the circulatory and respiratory systems

1054

4067

1.30

13.53

1.3

1.4

7.13

6.90

mmol/l

1.70

948

3641

Headache

703

4139

1.36

13.27

1.4

1.3

7.07

6.97

mmol/l

0.39

641

3676

Dental pulpitis, including avohilmo

951

4732

1.31

13.27

1.5

1.3

7.06

6.96

mmol/l

0.53

860

4248

Diseases of pulp and periapical tissues and dental caries

543

1946

1.43

12.88

1.3

7.35

7.17

mmol/l

0.67

485

1691

Spontaneous abortion

523

2500

1.42

12.26

1.5

1.4

6.85

6.79

mmol/l

0.18

475

2276

Pure hypercholesterolaemia

557

2605

1.40

12.14

1.2

7.69

7.41

mmol/l

1.19

496

2264

Dorsopathies

1028

4086

1.28

11.85

1.4

7.10

6.97

mmol/l

0.71

936

3624

Carpal tunnel syndrome

523

3310

1.40

11.84

1.4

1.3

7.40

7.22

mmol/l

0.74

470

2905

Soft tissue disorders

1017

4093

1.28

11.79

1.4

7.02

6.98

mmol/l

0.20

912

3647

Other dorsopathies, not elsewhere classified

998

4081

1.28

11.65

1.4

7.12

6.97

mmol/l

0.84

904

3621

Haemorrhage in early pregnancy

287

1804

1.56

11.43

1.5

1.3

6.86

6.67

mmol/l

0.62

267

1641

Fitting and adjustment of other devices

238

1333

1.62

11.07

1.3

1.2

8.05

7.65

mmol/l

0.97

192

1140

Other abnormal products of conception

447

2083

1.43

10.98

1.6

1.4

6.52

6.63

mmol/l

0.47

407

1908

Other soft tissue disorders, not elsewhere classified

892

4071

1.29

10.97

1.4

7.02

6.97

mmol/l

0.18

799

3628

Hyperlipidaemia, other/unspecified

256

1493

1.59

10.96

1.2

8.23

7.59

mmol/l

2.00

201

1272

Defect, injury or illness of lumbar spine

12.85

10.44

1.6

1.3

6.38

7.35

mmol/l

0.85

Failed induction of labour

102

506

2.06

10.36

1.9

1.5

6.54

6.56

mmol/l

0.04

465

Other and unspecified nerve root and plexus disorders, also in other diseases

192

1156

1.67

10.32

1.3

7.21

mmol/l

0.01

168

1035

Procreative management

264

1422

1.56

10.28

1.5

1.2

7.05

7.31

mmol/l

0.82

244

1256

Antepartum haemorrhage, not elsewhere classified

112

578

1.97

10.13

1.8

1.4

6.57

6.78

mmol/l

0.47

105

526

Angina pectoris

380

1766

1.44

9.82

1.2

7.69

7.62

mmol/l

0.15

318

1513

Maternal care for known or suspected disproportion

228

2.55

9.66

1.3

6.64

7.21

mmol/l

1.04

210

Dorsalgia

955

4077

1.26

9.63

1.4

7.13

6.97

mmol/l

0.99

861

3617

1042

4331

1.25

9.60

1.4

1.3

7.17

7.05

mmol/l

0.75

947

3814

Exposure to unspecified factor

588

5537

0.76

9.38

1.3

1.4

7.12

7.04

mmol/l

0.30

532

4918

Multiple delivery

344

2.21

9.31

1.4

1.2

6.72

7.86

mmol/l

3.47

309

Artrosis, including avohilmo

698

2947

1.30

9.21

1.2

1.3

7.32

7.23

mmol/l

0.32

621

2595

Iron deficiency

199

2.64

9.17

1.7

1.5

6.46

6.48

mmol/l

0.02

183

Asthma, including avohilmo

1089

4979

1.23

9.16

1.4

1.3

7.17

7.01

mmol/l

0.97

993

4409

Lumbar disc prolapse

554

3205

1.33

9.12

1.3

7.33

7.20

mmol/l

0.49

497

2813

Antihypertensive medication - note that there are other indications

688

2814

1.30

9.05

1.4

1.5

7.16

6.35

mmol/l

12.34

635

2531

Other retinal disorders

215

2572

0.65

8.95

1.2

1.3

7.59

7.44

mmol/l

0.28

186

2223

Asthma, excluding more controls

751

3066

1.28

8.81

1.4

1.3

7.28

6.98

mmol/l

1.89

682

2678

Pregnancy with abortive outcome

684

2762

1.30

8.80

1.5

1.4

6.83

6.82

mmol/l

0.04

611

2479

Transient ischemic attack

323

1820

1.44

8.75

1.2

7.28

7.72

mmol/l

1.72

290

1533

Asthma (mode)

751

3157

1.28

8.66

1.4

1.3

7.26

7.01

mmol/l

1.45

681

2758

Speech therapy

203

1297

1.57

8.63

1.2

1.3

7.36

7.50

mmol/l

0.29

154

1139

Obesity, other/unspecified

339

2404

1.42

8.60

1.4

1.3

7.39

6.88

mmol/l

2.89

303

2175

Flat foot [pes planus] (acquired)

471

1.97

8.56

1.3

7.43

7.31

mmol/l

0.15

422

Asthma

760

3139

1.27

8.50

1.4

1.3

7.28

7.01

mmol/l

1.65

689

2741

Migraine

530

3266

1.32

8.41

1.4

6.71

6.76

mmol/l

0.16

491

2946

Other intervertebral disc disorders

732

3474

1.27

8.35

1.3

7.25

7.12

mmol/l

0.57

652

3057

Placenta praevia

289

2.26

8.34

1.8

1.4

6.25

7.16

mmol/l

2.96

261

Provisional assignment of new diseases of uncertain etiology

471

3534

1.34

8.30

1.3

1.4

6.91

7.03

mmol/l

0.35

318

3188

Contraceptive management

356

1783

1.41

8.24

1.3

1.2

6.97

7.25

mmol/l

1.10

326

1573

Codes for special purposes

471

3540

1.33

8.21

1.3

1.4

6.91

7.03

mmol/l

0.35

318

3194

Maternal care for known or suspected fetal abnormality and damage

185

1007

1.59

8.09

1.8

1.4

6.15

6.73

mmol/l

3.85

173

915

Diseases of oral cavity, salivary glands and jaws

448

1701

1.36

8.00

1.3

1.2

7.40

7.28

mmol/l

0.36

396

1465

Metabolic disorders

771

3759

1.25

7.89

1.3

7.69

7.15

mmol/l

4.74

681

3323

Rotator cuff syndrome

460

2477

1.34

7.84

1.2

7.52

7.43

mmol/l

0.24

399

2154

Any event in cancer register

578

4362

0.78

7.77

1.2

1.3

7.37

7.02

mmol/l

1.93

527

3859

Functional dyspepsia

233

1572

1.49

7.76

1.3

7.13

7.26

mmol/l

0.27

205

1396

Ischemic heart diseases

605

2831

1.29

7.63

1.2

7.51

7.45

mmol/l

0.18

539

2467

Persons encountering health services in other circumstances

359

2615

1.37

7.57

1.4

7.07

6.94

mmol/l

0.38

333

2307

Spondylolisthesis/Spondylolysis

145

884

1.65

7.56

1.3

1.2

6.98

7.42

mmol/l

0.96

131

771

Twin gestation

102

565

1.83

7.53

1.5

1.3

6.41

6.87

mmol/l

1.35

506

Migraine with aura

274

1928

1.43

7.36

1.4

1.5

6.79

6.71

mmol/l

0.21

254

1752

Retained placenta and membranes, without haemorrhage

126

748

1.70

7.32

1.5

1.3

6.75

6.95

mmol/l

0.35

115

665

Type of accident

251

1740

1.45

7.30

1.4

1.3

7.11

7.12

mmol/l

0.01

230

1548

Nerve, nerve root and plexus disorders

920

4632

1.22

7.28

1.4

1.3

7.35

7.08

mmol/l

2.07

826

4095

Percutaneous Coronary Intervention

557

2652

1.29

7.25

1.2

7.49

7.50

mmol/l

0.01

493

2304

Dentofacial anomalies [including malocclusion]

691

4451

1.25

7.21

1.4

6.66

6.95

mmol/l

2.37

618

4012

Cholecystectomy

546

3679

1.28

7.16

1.3

7.71

7.21

mmol/l

3.35

463

3241

Rheumatism, unspecified

111

640

1.75

7.15

1.3

1.2

7.19

7.56

mmol/l

0.67

103

560

Lyme disease

1704

0.57

7.14

1.2

1.3

6.76

7.40

mmol/l

1.57

1512

Septicaemia

129

1957

0.61

7.09

1.2

1.3

7.52

7.43

mmol/l

0.14

113

1671

Any operation in hilmo

2.70

7.06

1.4

1.1

7.84

6.98

mmol/l

0.90

Other pulmonary diagnosis

782

3166

1.24

7.06

1.3

7.29

7.00

mmol/l

1.65

708

2767

Multiple gestation

103

586

1.78

6.99

1.5

1.3

6.41

6.90

mmol/l

1.48

525

Exclusions for E4_PCOS_CONSORTIUM

476

3852

0.77

6.96

1.3

1.4

7.25

6.84

mmol/l

2.58

425

3471

Leisure time condition

156

991

1.58

6.92

1.4

7.09

7.13

mmol/l

0.05

140

890

Persons encountering health services for examination and investigation

616

2438

1.27

6.84

1.3

6.95

6.94

mmol/l

0.02

541

2173

Coronary revascularization (ANGIO or CABG)

554

2654

1.28

6.84

1.2

7.53

7.50

mmol/l

0.07

491

2305

Gonarthrosis

488

2138

1.30

6.80

1.2

7.25

7.41

mmol/l

0.52

430

1861

Other septicaemia

110

1763

0.60

6.80

1.2

1.3

7.38

7.44

mmol/l

0.09

1498

Spirochaetal infections, other/unspecified

101

1713

0.59

6.72

1.2

1.3

6.79

7.39

mmol/l

1.48

1520

Other spirochaetal diseases

102

1723

0.59

6.69

1.2

1.3

6.73

7.39

mmol/l

1.73

1530

Dipeptidyl peptidase 4 (DPP-4) inhibitors

159

1946

0.65

6.64

1.2

11.22

6.81

mmol/l

18.27

128

1673

Pre-eclampsia or poor fetal growth

360

2689

1.34

6.62

1.6

1.5

6.43

6.70

mmol/l

1.69

333

2468

Diseases of the respiratory system

617

2453

1.26

6.59

1.3

7.21

6.97

mmol/l

1.04

555

2138

ILD differential diagnosis

774

3157

1.23

6.56

1.3

7.30

7.01

mmol/l

1.75

703

2758

COPD differential diagnosis

774

3159

1.23

6.52

1.3

7.30

7.01

mmol/l

1.76

703

2760

Covid-19 confirmed case

282

2039

1.39

6.51

1.4

1.3

6.78

7.24

mmol/l

2.10

250

1828

Excluding asthma or asthma-COPD overlap

775

3166

1.23

6.48

1.3

7.30

7.00

mmol/l

1.81

703

2767

Fall on same level

785

5204

0.82

6.47

1.4

7.11

7.01

mmol/l

0.42

703

4631

Combinations of oral blood glucose lowering drugs

1244

0.53

6.42

1.1

1.2

10.88

6.85

mmol/l

5.80

1072

Other blood glucose lowering drugs, excl. Insulins

590

0.32

6.41

1.2

8.92

6.89

mmol/l

0.85

505

Heart failure and bmi 25plus

1123

0.59

6.38

1.2

8.32

7.70

mmol/l

1.15

918

Ischaemic heart disease, wide definition

517

2509

1.28

6.37

1.2

7.56

7.54

mmol/l

0.06

447

2181

Preterm labour and delivery

232

1631

1.43

6.33

1.4

1.3

7.13

6.91

mmol/l

0.60

218

1468

Spondylosis

373

2297

1.33

6.31

1.2

7.33

7.49

mmol/l

0.47

336

1975

Disorders of choroid and retina

352

3310

0.75

6.28

1.2

1.3

7.46

7.40

mmol/l

0.15

292

2886

Hard cardiovascular diseases

616

2944

1.25

6.24

1.2

7.49

7.40

mmol/l

0.28

555

2570

Solid cancers, helper endpoint

472

3553

0.78

6.20

1.2

1.3

7.48

7.21

mmol/l

1.12

428

3120

Shoulder lesions

583

2817

1.26

6.19

1.2

1.3

7.57

7.33

mmol/l

0.98

498

2461

Other spirochaetal diseases

106

1737

0.61

6.19

1.3

6.80

7.39

mmol/l

1.50

1542

COPD/asthma related infections

956

4005

1.20

6.17

1.4

1.3

7.22

7.00

mmol/l

1.47

869

3533

COPD/asthma/ILD related infections

956

4005

1.20

6.17

1.4

1.3

7.22

7.00

mmol/l

1.47

869

3533

Malignant neoplasm, wide definition for exclusion

511

3779

0.79

6.12

1.2

1.3

7.39

7.17

mmol/l

0.98

465

3331

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

412

1992

1.31

6.11

1.3

7.12

6.90

mmol/l

0.75

376

1756

134

2.59

6.08

1.3

7.04

7.45

mmol/l

0.27

117

Asthma (only as main-diagnosis), excluding more controls

662

3066

1.24

6.08

1.4

1.3

7.18

6.98

mmol/l

0.94

597

2678

Excessive earwax

373

2776

1.31

6.06

1.3

7.53

7.36

mmol/l

0.53

343

2392

Arthrosis

566

2471

1.26

6.05

1.2

1.3

7.41

7.28

mmol/l

0.39

497

2164

Gingivitis and periodontal diseases

881

3785

1.20

6.03

1.3

7.33

7.06

mmol/l

1.70

774

3365

Asthma (only as main-diagnosis)

668

3139

1.23

6.02

1.4

1.3

7.16

7.01

mmol/l

0.67

601

2741

Hypothyroidism and >3 levothyroxin purchases

340

1434

1.35

5.97

1.4

1.5

7.07

6.15

mmol/l

6.72

312

1289

Hypothyroidism, levothyroxine purchases

340

1434

1.35

5.97

1.4

1.5

7.07

6.15

mmol/l

6.72

312

1289

Major coronary heart disease event

579

2798

1.25

5.95

1.2

7.51

7.49

mmol/l

0.05

513

2431

Pain in throat and chest

758

3755

1.21

5.89

1.3

1.4

7.20

6.97

mmol/l

1.34

680

3344

Autoimmune diseases excluding thyroid diseases

688

4568

0.82

5.84

1.4

1.3

7.31

6.96

mmol/l

2.07

605

4069

Gonarthrosis,primary

602

2991

1.24

5.83

1.2

7.25

7.55

mmol/l

1.55

528

2588

Emergency coronary revascularization (for ACS)

571

2783

1.25

5.83

1.2

7.54

7.53

mmol/l

0.04

503

2414

Malignant neoplasm

484

3607

0.79

5.78

1.2

1.3

7.44

7.20

mmol/l

0.95

437

3168

Hypothyroidism (congenital or acquired)

339

1436

1.34

5.76

1.4

1.5

7.08

6.14

mmol/l

6.80

311

1291

Other arthrosis

383

2033

1.31

5.76

1.2

7.24

7.43

mmol/l

0.67

348

1769

Pain (limb, back, neck, head abdominally)

666

2716

1.23

5.73

1.3

7.23

7.06

mmol/l

0.73

597

2396

Pain in joint

529

2691

1.26

5.71

1.4

1.3

7.09

7.04

mmol/l

0.13

480

2375

Malignant neoplasm of breast, including Hilmo

191

1772

0.70

5.68

1.2

1.3

7.47

7.25

mmol/l

0.49

175

1565

Malignant neoplasm of breast, HER2-negative, including Hilmo

191

1772

0.70

5.68

1.2

1.3

7.47

7.25

mmol/l

0.49

175

1565

Abnormalities of breathing

837

4063

1.20

5.67

1.3

1.4

7.27

6.90

mmol/l

3.07

745

3637

Malignant neoplasm of breast

184

1730

0.69

5.67

1.2

1.3

7.48

7.27

mmol/l

0.44

169

1524

Spondylopathies

590

2846

1.24

5.65

1.3

7.42

7.32

mmol/l

0.35

532

2471

Other diseases of pleura

127

1709

0.65

5.54

1.2

8.16

7.69

mmol/l

1.06

110

1450

Complications predominantly related to the puerperium

296

2220

1.34

5.53

1.6

1.5

6.67

6.73

mmol/l

0.17

271

2024

Gonarthrosis [arthrosis of knee](FG)

564

2641

1.24

5.52

1.2

7.24

7.41

mmol/l

0.66

493

2300

Mouth breathing

296

2219

1.34

5.47

1.2

1.3

7.19

7.30

mmol/l

0.25

263

1957

Deforming dorsopathies

228

1644

1.39

5.45

1.3

7.12

7.16

mmol/l

0.07

206

1442

Disorders of the thyroid gland

851

4663

1.19

5.45

1.3

1.4

7.26

6.96

mmol/l

2.06

763

4150

Pneumonias (Asthma/COPD co-morbidities)

632

5152

0.82

5.44

1.3

7.37

7.00

mmol/l

2.36

561

4575

Supplementary factors related to causes of morbidity and mortality classified elsewhere

260

1916

1.36

5.43

1.4

1.3

7.07

7.12

mmol/l

0.08

237

1708

Renal tubulo-interstitial diseases

503

4640

0.81

5.34

1.3

1.4

7.43

7.05

mmol/l

2.38

449

4104

Persons encountering health services for specific procedures, not carried out

443

0.29

5.33

1.3

1.4

7.80

7.05

mmol/l

0.21

401

Autoimmune diseases excluding thyroid diseases, strict definition

678

4478

0.83

5.30

1.4

7.30

6.95

mmol/l

2.06

596

3990

Other bacterial diseases

516

4286

0.81

5.29

1.2

1.3

7.67

7.17

mmol/l

3.17

451

3776

Spinal stenosis

301

1720

1.33

5.26

1.2

7.73

7.68

mmol/l

0.09

266

1455

Diseases of arteries, arterioles and capillaries

253

2513

0.74

5.18

1.2

7.94

7.49

mmol/l

1.46

219

2163

General symptoms and signs

1018

4363

1.17

5.15

1.4

1.3

7.12

7.01

mmol/l

0.55

914

3874

Pain in limb

714

3980

1.20

5.15

1.4

7.05

6.97

mmol/l

0.30

631

3542

Primary gonarthrosis, bilateral

299

1937

1.33

5.14

1.2

7.49

7.73

mmol/l

0.69

262

1648

Factors influencing health status and contact with health services

227

814

1.40

5.12

1.3

1.2

7.12

7.30

mmol/l

0.38

203

699

Cholelithiasis

661

3774

1.21

5.11

1.3

7.79

7.11

mmol/l

6.62

563

3337

Gastro-oesophageal reflux disease

523

3662

1.23

5.10

1.3

7.00

7.24

mmol/l

1.18

470

3211

Other diseases of upper respiratory tract

953

4240

1.17

5.00

1.3

7.12

7.09

mmol/l

0.11

852

3747

Malignant neoplasm of breast, HER2-negative

184

1694

0.71

5.00

1.2

1.3

7.47

7.29

mmol/l

0.37

169

1491

Familial hypercholesterolemia

514

1.68

4.99

1.2

8.11

7.75

mmol/l

0.40

435

Explicit Sepsis

166

2206

0.70

4.96

1.3

7.20

7.34

mmol/l

0.30

148

1898

COPD, hospital admissions 3, with asthma pneumonia sepsis

829

0.53

4.96

1.3

1.2

8.30

7.86

mmol/l

0.40

689

All pneumoniae

644

5164

0.83

4.93

1.3

7.35

7.01

mmol/l

2.27

572

4585

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

613

5027

0.83

4.83

1.3

7.39

7.03

mmol/l

2.33

545

4458

Triptan medication for migraine, single purchase ok

739

4216

1.19

4.78

1.4

6.93

mmol/l

0.00

673

3804

Migraine, single triptan purchase ok & required. ICD-code if available is included

739

4216

1.19

4.78

1.4

6.93

mmol/l

0.00

673

3804

STROKE

411

2219

1.26

4.75

1.2

7.25

7.28

mmol/l

0.08

362

1944

Sequelae of cerebrovascular disease

1258

0.63

4.73

1.3

1.2

7.31

7.81

mmol/l

0.77

1052

Chronic diseases of tonsils and adenoids

737

3925

1.19

4.71

1.4

6.91

7.00

mmol/l

0.34

666

3505

Other enthesopathies

233

1733

1.35

4.66

1.3

7.55

7.30

mmol/l

0.63

209

1540

Disorders of synovium and tendon

448

3170

1.24

4.63

1.3

7.25

7.10

mmol/l

0.54

412

2805

Other obstructed labour

459

1.69

4.58

1.4

1.3

7.41

7.01

mmol/l

0.52

409

Bacterial Sepsis

163

1959

0.71

4.56

1.2

8.09

7.52

mmol/l

1.39

143

1664

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

711

3610

1.19

4.51

1.3

10.26

6.46

mmol/l

87.62

613

3199

L04AA Selective immunosuppressants

1338

0.62

4.49

1.3

7.33

7.16

mmol/l

0.22

1201

Benzodiazepine use

653

5336

0.84

4.49

1.3

1.4

7.48

7.00

mmol/l

4.05

599

4724

Cardiovascular diseases

680

3066

1.20

4.48

1.4

6.92

6.59

mmol/l

2.55

620

2769

COPD, hospital admission 2, with asthma infections

1065

0.61

4.48

1.4

1.2

7.93

7.81

mmol/l

0.12

893

All chronic kidney diseases

222

2425

0.75

4.46

1.3

7.76

7.38

mmol/l

1.06

198

2093

Cholelithiasis, broad definition with cholecystitis

680

3855

1.19

4.43

1.3

7.77

7.10

mmol/l

6.54

582

3407

Influenza and pneumonia

707

5294

0.85

4.40

1.3

1.4

7.28

6.99

mmol/l

1.86

635

4706

Gastrointestinal diseases

629

2628

1.20

4.38

1.4

6.93

6.82

mmol/l

0.47

573

2355

Postpartum hemorraghe, all women as controls

327

2535

1.28

4.34

1.6

1.5

6.32

6.58

mmol/l

1.88

309

2326

Disorders of muscles

481

1.65

4.34

1.4

1.3

6.83

7.30

mmol/l

0.77

423

Neurological diseases, wide definition

330

1290

1.29

4.30

1.4

1.5

6.82

6.18

mmol/l

4.48

297

1151

Examination and encounter for administrative purposes

171

2.13

4.29

1.3

8.62

7.45

mmol/l

1.03

150

Pilonidal cyst

522

1.62

4.28

1.4

7.10

6.80

mmol/l

0.53

478

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

343

4176

0.80

4.24

1.4

6.69

6.91

mmol/l

0.97

325

3750

Hypothyroidism, other/unspecified

790

4449

1.17

4.23

1.3

1.4

7.34

6.95

mmol/l

2.88

705

3956

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

598

4900

0.84

4.19

1.3

7.22

7.10

mmol/l

0.43

531

4339

Sleep disorders

789

4899

1.17

4.11

1.3

1.4

6.89

7.02

mmol/l

0.70

734

4339

Cervical disc disorders

243

1859

1.31

4.05

1.2

7.65

7.46

mmol/l

0.38

224

1604

Insomnia

778

4873

1.17

4.04

1.3

1.4

6.86

7.00

mmol/l

0.77

723

4327

Allergic conjunctivitis

361

4355

0.81

4.04

1.4

6.69

6.92

mmol/l

1.02

340

3909

Poor fetal growth

176

1287

1.38

4.04

1.7

1.6

6.18

6.59

mmol/l

2.23

164

1190

Acute nasopharyngitis (common cold)

103

676

1.52

4.03

1.2

1.3

6.63

7.20

mmol/l

1.42

603

Pneumonia, organism unspecified

550

4594

0.84

4.02

1.3

7.48

7.09

mmol/l

2.33

490

4059

Disorders of lens

304

2404

0.79

4.00

1.2

7.52

7.53

mmol/l

0.02

263

2096

Exposure to other specified factors

465

5149

0.83

4.00

1.3

1.4

6.99

7.04

mmol/l

0.17

431

4569

Other noninflammatory disorders of cervix uteri

197

2.00

3.98

1.3

7.23

7.38

mmol/l

0.12

173

Diseases of male genital organs

308

1213

1.28

3.97

1.1

7.40

7.60

mmol/l

0.47

275

1050

Behavioural syndromes associated with physiological disturbances and physical factors

809

4955

1.16

3.95

1.3

1.4

6.89

7.04

mmol/l

0.82

748

4387

Senile cataract

257

2032

0.77

3.94

1.2

7.59

7.58

mmol/l

0.01

223

1758

Other specified/unspecified soft tissue disorders

185

2.02

3.89

1.4

1.3

7.35

7.58

mmol/l

0.17

162

Cough

304

2276

1.27

3.88

1.3

6.96

7.16

mmol/l

0.60

265

2005

Arthropathies

883

3881

1.15

3.86

1.3

1.4

7.00

6.88

mmol/l

0.59

798

3472

Brachial plexus disorders

592

1.55

3.86

1.3

7.66

7.02

mmol/l

1.31

535

Malignant neoplasm of digestive organs

116

1324

0.69

3.85

1.2

7.87

7.66

mmol/l

0.31

106

1112

Abdominal and pelvic pain

891

3886

1.15

3.85

1.4

1.3

7.29

7.06

mmol/l

1.36

785

3449

Other neurological diseases

478

3116

1.21

3.83

1.3

7.26

7.38

mmol/l

0.34

427

2710

Other and unspecified tonsillitis

354

2398

1.25

3.83

1.4

6.78

6.70

mmol/l

0.22

329

2167

Other joint disorders

849

3880

1.16

3.81

1.3

1.4

6.91

6.88

mmol/l

0.13

774

3471

Other female pelvic inflammatory diseases

140

995

1.42

3.80

1.3

1.4

6.99

7.13

mmol/l

0.32

128

889

Other appendicitis

414

1.65

3.80

1.4

1.3

6.98

7.22

mmol/l

0.29

366

Substance abuse, excluding more controls

311

3315

0.80

3.80

1.3

7.50

7.06

mmol/l

1.71

283

2926

Other bacterial diseases

623

4636

0.85

3.75

1.3

7.59

7.09

mmol/l

3.68

555

4096

Renal failure

138

1699

0.72

3.73

1.2

8.59

7.63

mmol/l

2.76

116

1425

Cardiac arrhythmias

523

2848

1.20

3.68

1.2

1.3

7.05

6.36

mmol/l

7.25

481

2554

Atherosclerosis, excluding cerebral and coronary sclerosis

107

1231

0.69

3.67

1.3

1.2

8.22

7.93

mmol/l

0.41

1013

295

3332

0.80

3.63

1.3

7.68

7.18

mmol/l

1.82

264

2942

Diseases of oesophagus, stomach and duodenum

886

4632

1.15

3.60

1.3

7.23

7.09

mmol/l

0.67

792

4104

Presence of other functional implants

215

1936

0.77

3.54

1.2

7.79

7.59

mmol/l

0.35

172

1651

Any dementia

875

0.66

3.54

1.3

1.2

7.96

7.97

mmol/l

0.01

692

Bleeding

407

3498

0.83

3.53

1.2

1.3

7.69

7.33

mmol/l

1.36

345

3063

Care involving dialysis

308

0.32

3.51

1.1

1.3

8.38

7.37

mmol/l

—

269

Varicose veins

403

2507

1.22

3.50

1.3

1.2

7.31

7.47

mmol/l

0.52

352

2179

Asthma, hospital admissions , main diagnosis only

679

5176

1.16

3.45

1.4

1.3

7.19

7.00

mmol/l

0.89

611

4594

Polycystic ovarian syndrome, broad definition

162

1203

1.36

3.44

1.7

1.6

6.85

6.44

mmol/l

1.50

146

1108

Malignant neoplasm of respiratory system and intrathoracic organs

638

0.57

3.43

1.2

8.24

7.79

mmol/l

0.33

524

ILD medications: immunosuppressive drugs

382

4289

0.83

3.43

1.4

1.3

7.24

7.06

mmol/l

0.55

354

3788

Acute tubulo-interstitial nephritis

342

3607

0.82

3.42

1.3

1.4

7.29

7.08

mmol/l

0.72

307

3173

Sciatica+with lumbago

397

3020

1.21

3.42

1.3

7.16

7.17

mmol/l

0.03

356

2646

Diseases of the musculoskeletal system and connective tissue

562

2387

1.18

3.40

1.4

6.78

6.84

mmol/l

0.20

510

2129

Allergic contact dermatitis

124

882

1.41

3.40

1.4

6.62

7.00

mmol/l

0.92

801

Bacterial infection, other or unspecified

220

2447

0.78

3.38

1.2

1.3

8.10

7.37

mmol/l

2.69

187

2105

Enthesopathies of lower limb, excluding foot

169

1265

1.34

3.37

1.3

7.26

7.22

mmol/l

0.07

149

1122

Hypothyreosis and Thyroxine purchase for inclusion criteria

801

4592

1.15

3.36

1.3

1.4

7.33

6.95

mmol/l

2.84

716

4082

Lower back pain or/and sciatica

899

5170

1.14

3.35

1.3

7.15

7.02

mmol/l

0.61

800

4598

Extracorporeal dialysis

206

0.29

3.35

1.2

1.3

8.23

7.32

mmol/l

—

182

Degenerative diseases of the nervous system

806

0.65

3.34

1.3

1.2

8.09

7.98

mmol/l

0.10

636

Abnormalities of forces of labour

670

1.47

3.33

1.6

1.3

6.77

6.89

mmol/l

0.22

602

Malignant neoplasm of bronchus and lung, including Hilmo

657

0.58

3.33

1.1

1.2

8.40

7.82

mmol/l

0.53

537

Mental and behavioural disorders due to psychoactive substance use

322

3656

0.81

3.33

1.3

7.51

7.13

mmol/l

1.39

289

3239

Family history of other specific disorders

2.52

3.33

2.2

1.5

6.34

7.04

mmol/l

0.82

Fever of other and unknown origin

302

3316

0.81

3.32

1.3

7.23

7.10

mmol/l

0.38

273

2916

Low back pain

647

4006

1.16

3.31

1.4

7.12

6.96

mmol/l

0.64

575

3551

Chronic lower respiratory diseases

1054

4987

1.13

3.30

1.4

1.3

7.23

6.99

mmol/l

1.84

960

4424

Cardiovascular diseases (excluding rheumatic etc)

655

3246

1.16

3.29

1.3

1.4

7.18

6.63

mmol/l

4.83

598

2922

Malignant neoplasm of skin

195

1737

0.77

3.28

1.2

7.74

7.56

mmol/l

0.33

171

1482

Coeliac disease

648

1.47

3.27

1.5

1.4

7.03

7.15

mmol/l

0.18

585

318

3429

0.81

3.26

1.3

7.74

7.17

mmol/l

2.41

285

3026

Infections of genitourinary tract in pregnancy

592

1.50

3.25

1.6

1.3

6.93

6.82

mmol/l

0.12

536

All kidney diseases

661

5202

0.87

3.22

1.3

1.4

7.34

6.99

mmol/l

2.53

596

4618

First line medication for Crohn's disease

810

4980

0.88

3.20

1.4

7.18

6.98

mmol/l

1.14

735

4411

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

669

1.46

3.19

1.7

1.4

6.44

6.87

mmol/l

1.11

605

Pre-eclampsia or eclampsia

206

1602

1.29

3.16

1.4

6.64

6.88

mmol/l

0.83

190

1456

Hyperplasia of prostate

209

914

1.30

3.14

1.1

7.53

7.70

mmol/l

0.26

182

782

Other anaemias

145

1845

0.75

3.13

1.2

7.43

7.59

mmol/l

0.23

120

1575

KRA_PSY_EATING, excluding more controls

934

0.63

3.12

1.5

1.6

6.35

6.44

mmol/l

0.12

854

Substance abuse

311

3566

0.82

3.12

1.3

7.50

7.15

mmol/l

1.20

283

3157

Other and unspecified anaemias

143

1826

0.74

3.11

1.2

7.41

7.59

mmol/l

0.27

119

1556

Pre-eclampsia

197

1528

1.30

3.09

1.4

6.66

6.86

mmol/l

0.60

183

1389

Labour and delivery complicated by umbilical cord complications

306

1.68

3.09

1.4

7.22

7.10

mmol/l

0.16

269

Bacterial infection, other or unspecified

255

2685

0.80

3.09

1.2

1.3

7.99

7.34

mmol/l

2.12

221

2319

ILD medications: prednisolone, methylprednisolone, prednisone

778

4947

0.88

3.07

1.3

7.24

6.99

mmol/l

1.66

707

4383

Other respiratory disorders and diseases

739

0.59

3.06

1.2

8.33

7.62

mmol/l

0.80

628

Other diseases of the respiratory system

739

0.59

3.06

1.2

8.33

7.62

mmol/l

0.80

628

Other/unspecified enthesopathies of lower limb, excluding foot

345

1.63

3.06

1.3

7.31

7.27

mmol/l

0.03

308

Bacterial pneumoniae

174

1994

0.77

3.03

1.3

7.62

7.32

mmol/l

0.69

152

1719

Reimbursement for rheumatic diseases

295

3590

0.82

3.03

1.3

7.21

7.17

mmol/l

0.08

269

3168

Inflammatory disorders of breast

513

1.52

3.02

1.7

1.5

6.27

6.74

mmol/l

1.50

462

Rheumatoid arthritis, including avohilmo

159

2088

0.76

3.02

1.3

7.59

7.37

mmol/l

0.38

140

1834

Gonarthrosis, primary, with knee surgery

310

2016

1.23

3.01

1.2

7.39

7.74

mmol/l

1.38

263

1714

severe traumatic brain injury, does not include concussion

884

0.63

3.01

1.4

1.2

7.60

mmol/l

0.00

751

Any dementia, excluding more controls

827

0.68

2.99

1.3

1.2

7.91

7.98

mmol/l

0.07

652

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

390

1625

1.21

2.99

1.3

1.4

6.91

6.82

mmol/l

0.24

350

1463

Peripheral artery disease

129

1390

0.74

2.98

1.3

1.2

8.49

7.86

mmol/l

1.29

109

1151

Other hearing loss

141

1026

1.35

2.97

1.3

1.2

8.30

7.67

mmol/l

1.22

126

870

Heart failure, not strict

343

2808

0.83

2.97

1.2

7.81

7.44

mmol/l

1.36

302

2421

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

0.00

2.96

0.0

1.2

—

7.92

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

356

1.61

2.96

1.3

7.67

7.19

mmol/l

0.64

318

Fracture of femur

854

0.65

2.95

1.3

1.2

7.76

mmol/l

0.00

703

Special screening examination for neoplasms

227

1.77

2.95

1.2

8.05

7.65

mmol/l

0.23

199

Malignant neoplasm of bronchus and lung

534

0.57

2.92

1.1

1.2

8.28

7.81

mmol/l

0.33

436

Oxycodone

137

1654

0.75

2.92

1.2

7.88

7.53

mmol/l

0.69

116

1383

Bacterial pneumonia (organism specified)

182

2120

0.78

2.91

1.3

7.60

7.37

mmol/l

0.47

157

1842

Examination and observation for other reasons

349

2430

0.83

2.91

1.3

7.06

6.94

mmol/l

0.38

315

2165

Alcohol use disorder, Swedish definition

275

3090

0.81

2.91

1.2

1.3

7.74

7.23

mmol/l

1.83

251

2718

Asthma (diagnoses ohter than nonallergic)

708

5163

1.14

2.87

1.3

1.4

7.16

7.02

mmol/l

0.64

644

4573

Covid-19 suspected case

198

1554

1.28

2.86

1.2

1.4

7.49

6.86

mmol/l

1.03

1430

Lateral epicondylitis

101

717

1.42

2.86

1.2

7.17

7.42

mmol/l

0.38

633

Other contact dermatitis

456

1.52

2.82

1.6

1.3

6.53

7.15

mmol/l

1.04

417

Viral warts

103

1424

0.72

2.81

1.3

1.4

6.87

6.93

mmol/l

0.07

1279

Malignant neoplasm of tongue

0.00

2.79

0.0

1.3

—

8.07

—

Kidney transplant status

206

0.34

2.79

1.3

7.77

7.38

mmol/l

—

181

L02BA Anti-estrogens

817

0.63

2.78

1.3

1.2

8.01

7.45

mmol/l

0.59

715

All-cause Heart Failure

193

1731

0.79

2.78

1.2

8.52

7.67

mmol/l

2.84

172

1448

Alzheimer disease, including avohilmo

749

0.68

2.77

1.3

1.2

8.07

8.02

mmol/l

0.04

577

Intrahepatic Cholestasis of Pregnancy (ICP)

606

1.45

2.77

1.7

1.5

6.24

6.79

mmol/l

1.96

557

Other cataract

169

1649

0.77

2.76

1.2

7.71

7.61

mmol/l

0.16

141

1414

Allergic asthma (mode), excluding more controls

227

1780

1.25

2.76

1.4

6.69

6.72

mmol/l

0.05

209

1574

Implicit Sepsis

467

3977

0.86

2.76

1.3

7.37

7.19

mmol/l

0.68

423

3485

Leiomyoma of uterus

347

2354

0.83

2.75

1.3

7.50

7.16

mmol/l

1.37

301

2093

Dementia

104

989

0.72

2.74

1.2

7.87

8.02

mmol/l

0.19

786

Allergic asthma (mode)

227

1782

1.25

2.74

1.4

6.69

6.72

mmol/l

0.05

209

1579

Heart failure,strict

189

1694

0.79

2.73

1.2

8.49

7.62

mmol/l

2.86

169

1415

Medical abortion

583

2744

1.15

2.73

1.4

6.82

6.81

mmol/l

0.05

531

2461

Tonsillectomy and adenotomy

573

3466

1.15

2.72

1.5

1.4

6.56

6.78

mmol/l

1.43

528

3151

Infective dermatitis

566

1.46

2.72

1.4

1.3

7.03

7.33

mmol/l

0.50

512

Organic, including symptomatic, mental disorders

155

1436

0.77

2.72

1.2

7.91

7.87

mmol/l

0.05

133

1190

Malignant neoplasm of breast, ER-positive, including Hilmo

140

1422

0.76

2.71

1.2

1.3

7.46

7.38

mmol/l

0.13

127

1244

Other headache syndromes

335

2796

1.20

2.71

1.3

1.4

7.03

6.97

mmol/l

0.15

312

2492

Nonalcoholic fatty liver disease

477

1.50

2.70

1.4

1.3

8.03

7.36

mmol/l

0.91

427

Disorders of gallbladder, biliary tract and pancreas

761

4247

1.13

2.70

1.3

7.75

7.09

mmol/l

7.21

655

3759

Meniscus derangement

394

2241

1.19

2.69

1.2

7.21

7.31

mmol/l

0.29

356

1958

Puerperal sepsis

104

752

1.39

2.68

1.4

1.3

6.89

7.22

mmol/l

0.68

675

Mental and behavioural disorders due to alcohol

266

3112

0.82

2.67

1.3

7.56

7.19

mmol/l

1.15

237

2745

Candidiasis

153

1981

0.77

2.67

1.2

1.4

7.06

6.97

mmol/l

0.20

143

1776

Unspecific neurodegenerative disorder

898

0.71

2.67

1.2

7.80

8.12

mmol/l

0.44

704

Pneumonitis due to solids and liquids

266

0.37

2.66

1.1

1.3

9.36

7.43

mmol/l

—

229

Intussusception

2.15

2.66

1.4

6.76

7.69

mmol/l

1.29

Other/unspecified dorsalgia

280

2285

1.22

2.65

1.4

1.3

7.00

7.09

mmol/l

0.23

251

2008

Implicit bacterial Sepsis

142

1643

0.76

2.62

1.2

8.28

7.63

mmol/l

1.49

126

1381

Osteoporosis

953

0.68

2.59

1.3

1.2

7.06

7.75

mmol/l

1.18

802

Hernia of abdominal wall

302

2512

1.20

2.59

1.3

7.41

7.36

mmol/l

0.12

266

2189

Mood [affective] disorders

873

5065

1.12

2.58

1.3

7.21

7.01

mmol/l

1.27

795

4487

Condition for Implicit Sepsis (Organ dysfunction codes)

508

4129

0.87

2.58

1.3

7.35

7.19

mmol/l

0.66

458

3627

Other or unspecified ileus, impaction or obstruction

753

0.64

2.58

1.3

1.2

7.33

7.73

mmol/l

0.46

646

Symptoms and signs involving the digestive system and abdomen

868

3886

1.12

2.56

1.3

7.21

7.06

mmol/l

0.75

771

3449

Abrasion of teeth

253

2071

1.23

2.56

1.3

6.95

7.25

mmol/l

0.90

225

1857

Mood disorders

874

5066

1.12

2.56

1.3

7.22

7.01

mmol/l

1.33

796

4488

Other enthesopathy of foot (+metatarsalgia)

533

1.45

2.54

1.3

7.63

7.42

mmol/l

0.25

466

Lung cancer and mesothelioma

634

0.63

2.54

1.1

1.2

8.35

7.78

mmol/l

0.54

514

Other disorders of eyelid

246

1912

1.23

2.53

1.2

7.59

7.64

mmol/l

0.07

208

1640

Malignant neoplasm of breast, ER-negative, including Hilmo

988

0.69

2.53

1.2

1.3

7.47

7.50

mmol/l

0.03

849

Other heart diseases

390

2161

1.18

2.53

1.2

1.3

7.27

6.84

mmol/l

2.04

359

1918

Female infertility, associated with anovulation

124

933

1.34

2.52

1.7

1.6

6.84

6.33

mmol/l

2.06

112

857

Neuralgia and neuritis, unspecified

224

1.71

2.51

1.3

7.53

7.48

mmol/l

0.02

195

Malignant neoplasm of breast, HER-positive

138

1402

0.77

2.51

1.2

7.51

7.38

mmol/l

0.21

125

1226

Alzheimer disease

639

0.66

2.51

1.3

1.2

8.05

mmol/l

0.00

490

Diseases of inner ear

342

2791

1.19

2.49

1.3

7.27

7.42

mmol/l

0.39

296

2430

Eating disorder

888

0.67

2.49

1.5

1.6

6.35

6.56

mmol/l

0.35

820

COPD, hospital admissions 1, only main diagnosis

1136

0.73

2.49

1.3

1.2

7.84

mmol/l

0.00

958

Dermatitis and eczema

920

5132

1.11

2.48

1.4

1.3

6.82

7.09

mmol/l

2.41

808

4574

Convergence insufficiency and excess

2.18

2.47

1.8

1.5

5.63

7.27

mmol/l

4.09

Hypothyroidism, drug reimbursement

140

753

1.32

2.47

1.3

1.4

7.22

6.28

mmol/l

3.99

123

669

Pain in thoracic spine

120

901

1.34

2.46

1.4

1.3

7.00

7.13

mmol/l

0.22

114

796

Heart failure, strict

200

1756

0.80

2.46

1.2

8.49

7.66

mmol/l

2.81

177

1470

Bacterial pneumonia, not elsewhere classified

166

1854

0.79

2.46

1.3

7.59

7.33

mmol/l

0.54

145

1602

Other degenerative diseases of the nervous system

999

0.73

2.45

1.4

1.3

7.24

7.53

mmol/l

0.40

845

Polycystic ovarian syndrome

581

1.43

2.43

1.9

1.6

6.91

6.58

mmol/l

0.63

533

COPD related to multimorbidity

117

1309

0.75

2.42

1.3

1.2

8.01

7.86

mmol/l

0.19

100

1099

Other and unspecified haemorrhagic conditions

0.00

2.40

0.0

1.4

—

7.54

—

Abnormal findings on examination of urine, without diagnosis

175

1.79

2.39

1.3

1.4

8.15

7.39

mmol/l

0.79

153

Caries of enamel

759

4895

1.12

2.38

1.4

1.3

6.82

7.05

mmol/l

1.70

707

4348

Inflammatory diseases of prostate (prostatitis)

458

1.47

2.38

1.2

7.30

7.53

mmol/l

0.29

397

Other condition

104

769

1.36

2.37

1.4

1.3

7.11

7.13

mmol/l

0.02

691

Coronary atherosclerosis

377

2030

1.18

2.37

1.2

7.66

7.59

mmol/l

0.18

328

1749

Benign neoplasm: Colon, unspecified

136

1046

1.30

2.36

1.3

1.2

7.82

7.77

mmol/l

0.06

103

894

Osteomyelitis

250

0.40

2.35

1.4

1.3

7.89

7.48

mmol/l

—

219

Non-allergic asthma (mode)

140

1071

1.30

2.35

1.4

1.3

7.46

7.09

mmol/l

0.77

123

924

Cerebrovascular diseases

329

2729

0.85

2.34

1.3

1.2

7.59

7.55

mmol/l

0.08

287

2352

Other disorders of binocular vision

2.22

2.33

2.0

1.5

6.31

7.44

mmol/l

1.76

Depression

821

5001

1.11

2.32

1.3

1.4

7.17

6.99

mmol/l

1.04

755

4444

Implicit bacterial Sepsis

168

1823

0.79

2.32

1.3

1.2

8.06

7.60

mmol/l

1.06

150

1540

Hand

3.04

2.31

1.8

1.6

9.10

7.13

mmol/l

—

Non-allergic asthma (mode), excluding more controls

140

1074

1.29

2.31

1.4

1.3

7.46

7.10

mmol/l

0.73

123

918

Obstructed labour due to maternal pelvic abnormality

106

790

1.35

2.31

1.5

1.3

7.45

7.28

mmol/l

0.25

710

Umbilical hernia

193

1555

1.24

2.31

1.3

7.29

mmol/l

0.01

168

1353

Metatarsalgia

487

1.44

2.29

1.3

7.72

7.42

mmol/l

0.36

426

Nausea and vomiting

120

1535

0.76

2.29

1.5

1.4

7.14

7.12

mmol/l

0.02

102

1352

Malignant neoplasm of oral cavity, including Hilmo

154

0.32

2.28

1.2

1.3

5.90

7.83

mmol/l

—

134

Malignant neoplasm of colon, including Hilmo

717

0.65

2.27

1.2

7.98

7.79

mmol/l

0.15

592

Arthropod-borne viral fevers and viral haemorrhagic fevers

455

1.46

2.27

1.3

7.37

7.27

mmol/l

0.10

404

Polypectomy (DHB20)

262

1.61

2.26

1.1

1.3

8.63

7.27

mmol/l

1.33

230

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

190

1597

0.81

2.26

1.2

7.82

7.63

mmol/l

0.34

163

1350

Ganglion

169

1345

1.26

2.26

1.3

7.31

7.13

mmol/l

0.33

161

1207

Malignant neoplasm of other and unspecified parts of tongue

0.00

2.25

0.0

1.3

—

8.17

—

Injuries to the head

779

5322

0.90

2.24

1.3

7.17

7.02

mmol/l

0.77

685

4747

Infections with a predominantly sexual mode of transmission

214

2601

0.82

2.24

1.4

1.5

7.11

6.68

mmol/l

1.53

201

2370

Acute pharyngitis

138

1064

1.29

2.23

1.5

1.4

7.11

6.78

mmol/l

0.86

130

961

Other disorders of skin and subcutaneous tissue

358

3703

0.86

2.22

1.2

1.3

7.19

7.27

mmol/l

0.17

320

3245

5-aminosalicylic acid

109

1434

0.76

2.22

1.3

6.70

7.04

mmol/l

0.79

1278

Seropositive rheumatoid arthritis, wide

102

1354

0.75

2.21

1.3

7.42

7.50

mmol/l

0.10

1183

COPD, early/later onset

149

1589

0.79

2.20

1.3

1.2

7.74

7.79

mmol/l

0.07

130

1349

Pedal cyclist injured in transport accident

108

1419

0.76

2.18

1.3

1.4

6.92

7.05

mmol/l

0.19

1280

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

100

1328

0.75

2.18

1.3

7.41

7.47

mmol/l

0.07

1158

Noninfective enteritis and colitis

251

2997

0.83

2.17

1.4

1.3

7.17

7.12

mmol/l

0.13

222

2665

Infections with a predominantly sexual mode of transmission

302

3310

0.85

2.17

1.5

6.89

6.66

mmol/l

0.83

286

3017

Glomerular diseases

852

0.69

2.16

1.3

7.47

7.41

mmol/l

0.06

752

Inflammatory bowel disease

167

2076

0.80

2.15

1.4

1.3

7.06

7.10

mmol/l

0.06

148

1860

Non-allergic asthma

386

1.48

2.15

1.7

1.3

7.71

7.18

mmol/l

0.57

339

Autoimmune diseases related-to ILD

552

5323

0.89

2.14

1.4

1.3

7.22

7.05

mmol/l

0.73

490

4731

Dementia, including avohilmo

119

1063

0.77

2.14

1.2

7.94

8.00

mmol/l

0.07

854

Other/unspecified seropositive rheumatoid arthritis

101

1335

0.75

2.13

1.3

7.44

7.49

mmol/l

0.06

1165

Implicit Sepsis

405

3516

0.87

2.13

1.3

7.43

7.27

mmol/l

0.53

363

3072

Impacted maxillary molar

537

1.41

2.13

1.6

6.15

6.47

mmol/l

0.78

496

Eating disorders

963

0.71

2.12

1.4

1.6

6.42

6.58

mmol/l

0.27

886

Aplastic and other anaemias

171

1974

0.81

2.12

1.2

7.26

7.55

mmol/l

0.62

143

1688

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

260

1.50

2.11

1.2

7.14

6.53

mmol/l

1.05

212

Second line medication for Crohn's disease

324

3780

0.86

2.11

1.4

1.3

7.28

7.12

mmol/l

0.42

297

3362

Other malignant neoplasms of skin (=non-melanoma skin cancer)

171

1455

0.80

2.10

1.1

1.2

7.89

7.62

mmol/l

0.53

145

1222

Intestinal stricture

106

1388

0.76

2.10

1.3

1.2

7.00

7.63

mmol/l

1.83

1198

Use of donepezil

512

0.62

2.09

1.1

1.2

7.62

8.03

mmol/l

0.28

399

Budesonide

869

0.70

2.09

1.4

7.21

7.06

mmol/l

0.16

777

Inflammatory disease of uterus

146

1156

1.27

2.08

1.7

1.5

7.34

6.78

mmol/l

1.44

137

1055

Other, unspecified and serous retinal detachments

110

1.93

2.06

1.2

7.26

7.57

mmol/l

0.20

Conjunctivitis

521

4909

0.88

2.06

1.4

6.87

6.97

mmol/l

0.37

490

4385

Other abnormal findings in urine

2.35

2.06

1.2

1.4

7.94

7.38

mmol/l

—

Malignant neoplasm of breast, HER-negative

862

0.70

2.06

1.2

1.3

7.50

7.51

mmol/l

0.01

740

Diabetes, insulin treatment (Kela reimbursement)

738

4012

1.11

2.05

1.3

10.25

6.69

mmol/l

81.17

638

3551

Oedema, not elsewhere classified

210

1709

1.21

2.04

1.4

1.3

7.36

7.33

mmol/l

0.05

173

1468

Disturbances of skin sensation

236

1970

1.20

2.04

1.4

6.56

7.01

mmol/l

1.85

211

1776

IBD patients in KELA-register

120

1539

0.78

2.04

1.4

6.95

6.99

mmol/l

0.05

105

1391

Inflammatory bowel disease, strict (require KELA)

120

1539

0.78

2.04

1.4

6.95

6.99

mmol/l

0.05

105

1392

COPD, hospital admissions

149

1577

0.80

2.03

1.3

1.2

7.74

7.78

mmol/l

0.06

130

1340

Lactose intolerance

147

1.78

2.03

1.5

7.01

7.29

mmol/l

0.24

129

Dialysis

144

0.35

2.02

1.2

1.3

7.84

7.46

mmol/l

—

124

Other benign neoplasm of uterus: Corpus uteri

2.87

2.02

1.1

1.4

8.91

7.43

mmol/l

—

Other (seronegative) rheumatoid arthritis, wide

921

0.71

2.01

1.3

7.80

7.51

mmol/l

0.24

803

Rheumatoid arthritis

140

1578

0.79

1.99

1.3

7.61

7.35

mmol/l

0.40

123

1392

Acute alcohol intoxication, ICD10

1218

0.75

1.99

1.3

7.55

7.10

mmol/l

0.60

1099

Generalized anxiety disorder

108

1398

0.77

1.99

1.3

1.5

6.88

6.58

mmol/l

0.52

1279

Mental and behavioural disorders due to alcohol, excluding acute intoxication

223

2656

0.83

1.98

1.2

1.3

7.52

7.28

mmol/l

0.54

202

2331

Use of hypnotics and sedatives

719

4573

0.90

1.98

1.2

1.3

7.30

7.12

mmol/l

0.76

643

4042

Sulfasalazine

148

1844

0.80

1.97

1.4

1.3

7.20

7.22

mmol/l

0.02

139

1632

591

4004

0.89

1.97

1.3

7.35

7.00

mmol/l

2.00

526

3532

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

591

4004

0.89

1.97

1.3

7.35

7.00

mmol/l

2.00

526

3532

Unspecified fall

249

2906

0.84

1.97

1.3

7.08

7.24

mmol/l

0.38

221

2547

Hypothyroidism, strict autoimmune

663

3916

1.11

1.97

1.3

1.4

7.33

6.91

mmol/l

2.72

588

3490

Anterior Iridocyclitis

1112

0.74

1.96

1.3

7.10

7.25

mmol/l

0.22

993

Social phobias

680

0.67

1.95

1.5

7.41

6.62

mmol/l

0.95

620

Contracture of muscle

3.86

1.95

1.2

1.3

6.68

7.55

mmol/l

—

COPD

151

1535

0.80

1.95

1.3

1.2

7.77

7.65

mmol/l

0.17

132

1293

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

649

1.35

1.94

1.3

6.83

7.37

mmol/l

1.13

576

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

112

1437

0.78

1.94

1.4

1.5

6.53

6.68

mmol/l

0.33

106

1299

Cervicobrachial syndrome

161

1301

1.24

1.94

1.3

7.43

7.19

mmol/l

0.53

141

1152

Acute and subacute iridocyclitis

1052

0.74

1.93

1.3

7.20

7.25

mmol/l

0.07

943

Alcohol use disorder, ICD-based

205

2464

0.83

1.92

1.2

1.3

7.48

7.25

mmol/l

0.49

186

2159

Iridocyclitis

1290

0.77

1.92

1.3

7.15

7.25

mmol/l

0.15

1156

Explicit bacterial Sepsis

472

0.61

1.91

1.3

7.65

7.33

mmol/l

0.19

405

Follow-up examination after treatment for conditions other than malignant neoplasms

373

2143

1.15

1.91

1.4

6.87

6.88

mmol/l

0.02

328

1918

Diseases of the skin and subcutaneous tissue

886

4052

1.10

1.88

1.4

1.3

7.22

7.02

mmol/l

1.20

786

3616

Anogenital herpesviral [herpes simplex] infection

941

0.73

1.86

1.4

1.5

6.58

6.72

mmol/l

0.19

857

Myocarditis

197

1.63

1.86

1.4

1.2

6.76

7.38

mmol/l

0.71

170

L04AX Other immunosuppressants

314

3630

0.86

1.86

1.4

1.3

7.30

7.14

mmol/l

0.39

290

3225

Coxarthrosis, primary, with hip surgery

226

1774

1.19

1.86

1.2

7.71

7.75

mmol/l

0.07

186

1496

Female infertility

349

1835

1.16

1.85

1.6

1.5

6.75

6.57

mmol/l

0.74

315

1683

Amenorrhoea

683

0.68

1.85

1.4

1.6

7.12

6.38

mmol/l

1.25

622

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

342

1.47

1.84

1.3

7.18

7.21

mmol/l

0.02

299

Nontraumatic intracranial haemmorrhage

754

0.70

1.84

1.2

7.68

7.72

mmol/l

0.03

636

Other symptoms and signs involving the nervous and musculoskeletal systems

305

2628

1.16

1.84

1.4

1.3

7.21

7.18

mmol/l

0.08

271

2339

Disorders of vestibular function (Vertigo)

284

2394

1.17

1.83

1.3

7.30

7.44

mmol/l

0.34

248

2080

Diarrhoea and gastroenteritis of presumed infectious origin

832

5004

1.10

1.83

1.3

7.10

7.05

mmol/l

0.23

751

4432

Carrier of infectious disease

101

1.90

1.81

1.4

7.16

7.39

mmol/l

0.11

Recurrent or chronic depression

382

2349

1.15

1.80

1.3

1.4

6.97

6.91

mmol/l

0.16

351

2089

Benign neoplasm: Adrenal gland

303

1.49

1.80

1.2

1.3

7.62

7.55

mmol/l

0.05

265

Fracture of rib(s), sternum and thoracic spine

114

1445

0.79

1.80

1.2

7.35

7.52

mmol/l

0.21

1250

Abnormalities of heart beat

250

2083

1.18

1.79

1.3

1.4

7.34

7.08

mmol/l

0.59

217

1851

Lichen planus

529

1.37

1.79

1.2

7.58

7.42

mmol/l

0.16

462

Hypothyroidism, strict autoimmune, 3 medication purchases required

712

4361

1.10

1.79

1.3

1.4

7.31

6.93

mmol/l

2.48

635

3884

Non-ischemic cardiomyopathy

929

0.76

1.79

1.1

1.2

8.52

7.66

mmol/l

1.56

778

Thoracic aortic aneurysm

548

0.65

1.78

1.1

1.2

7.27

7.78

mmol/l

0.67

467

Female infertility, cervical, vaginal, other or unspecified origin

315

1768

1.16

1.78

1.5

6.64

6.58

mmol/l

0.20

287

1621

Basal cell carcinoma

165

1393

0.82

1.78

1.1

1.2

7.90

7.64

mmol/l

0.49

139

1167

Intestinal adhesions without obstruction

325

0.55

1.78

1.4

1.3

8.08

7.57

mmol/l

0.38

285

Acute alcohol intoxication

114

1442

0.79

1.77

1.3

7.67

7.19

mmol/l

0.79

1280

Atrial fibrillation and flutter

200

1077

1.21

1.77

1.2

7.64

7.17

mmol/l

1.35

185

927

Persons encountering health services for specific procedures and health care

891

4896

1.09

1.76

1.3

1.4

7.43

6.96

mmol/l

4.57

776

4387

Cerebrovascular diseases (FINNGEN)

213

1261

1.20

1.76

1.3

1.2

7.44

7.10

mmol/l

0.73

191

1100

Temporomandibular joint disorders, including avohilmo

415

3615

1.13

1.76

1.4

6.67

6.79

mmol/l

0.48

375

3298

Trigger finger

730

1.31

1.76

1.2

7.54

7.52

mmol/l

0.01

636

Diverticular disease of intestine

449

2536

1.13

1.76

1.2

7.31

7.54

mmol/l

0.98

375

2208

Symptoms and signs involving the skin and subcutaneous tissue

528

4632

1.12

1.74

1.4

1.3

6.93

7.08

mmol/l

0.66

471

4094

Later onset COPD

633

0.72

1.74

1.2

8.19

8.06

mmol/l

0.12

496

Lower leg

2.97

1.73

1.3

8.00

7.41

mmol/l

—

Dental caries

161

1268

1.22

1.73

1.3

7.45

7.20

mmol/l

0.47

137

1097

Other medical care

189

2034

0.83

1.72

1.2

1.3

7.87

7.38

mmol/l

1.57

173

1776

Disorders of conjunctiva

574

5107

0.90

1.72

1.4

6.93

7.00

mmol/l

0.20

528

4542

Asthma/COPD (KELA code 203)

795

4983

1.09

1.71

1.3

7.13

6.99

mmol/l

0.69

719

4420

Unstable angina pectoris

172

1118

1.22

1.70

1.2

7.86

7.81

mmol/l

0.06

144

937

Achilles tendinitis

492

1.37

1.69

1.2

7.52

7.37

mmol/l

0.14

439

Benign neoplasm: Colon

284

2343

1.16

1.67

1.2

7.55

7.66

mmol/l

0.23

234

2008

Ovarian dysfunction

738

1.30

1.65

1.8

1.6

7.24

6.64

mmol/l

1.11

682

Any reimbursement code in KELA

629

2850

1.11

1.65

1.4

7.35

6.28

mmol/l

14.96

572

2558

Basal cell carcinoma, including avohilmo

180

1487

0.83

1.65

1.1

1.2

7.78

7.61

mmol/l

0.30

153

1252

Congenital malformations of the urinary system

291

0.55

1.64

1.4

7.27

6.99

mmol/l

0.21

260

Ulcerative colitis

126

1559

0.81

1.64

1.3

7.12

7.05

mmol/l

0.10

110

1401

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1124

0.77

1.64

1.3

6.74

7.00

mmol/l

0.49

1014

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1043

0.77

1.63

1.2

8.10

7.66

mmol/l

0.76

867

Migraine with aura and triptan purchases

166

1376

1.21

1.63

1.4

1.5

6.78

6.65

mmol/l

0.25

151

1260

Necrosis of pulp, including avohilmo

477

4265

1.12

1.61

1.4

1.3

7.43

7.01

mmol/l

1.94

416

3828

Liquid cancers, helper endpoint

149

1577

0.82

1.60

1.2

7.68

7.53

mmol/l

0.23

130

1344

Ocular pain

447

1.37

1.58

1.3

1.4

7.15

7.08

mmol/l

0.06

403

Car occupant injured in other and unspecified transport accidents

153

1262

1.22

1.58

1.6

1.4

6.89

6.87

mmol/l

0.04

145

1145

Colorectal cancer

894

0.75

1.57

1.2

8.05

7.72

mmol/l

0.39

739

Extrapyramidal and movement disorders

155

1868

0.83

1.57

1.3

1.2

7.39

7.52

mmol/l

0.23

135

1615

Follicular cysts of skin and subcutaneous tissue

122

984

1.24

1.56

1.2

1.3

7.69

7.19

mmol/l

0.86

103

876

Ulcerative colitis (strict definition, all Crohn cases excluded)

867

0.75

1.56

1.3

1.4

6.65

6.97

mmol/l

0.64

788

Prolapse and hernia of ovary and fallopian tube

2.05

1.56

1.7

1.2

9.88

8.46

mmol/l

0.77

Malignant neoplasm of head and neck

285

0.56

1.54

1.1

1.2

7.12

7.64

mmol/l

0.21

240

Blepharochalasis

150

1238

1.21

1.54

1.3

1.2

7.59

7.76

mmol/l

0.25

123

1057

Lactose intolerance, other/unspecified

130

1.71

1.53

1.4

1.5

7.18

7.33

mmol/l

0.10

115

Other benign neoplasms of connective and other soft tissue

441

1.37

1.53

1.4

1.3

6.82

7.25

mmol/l

0.67

391

Cutis laxa senilis

2.63

1.52

1.3

1.2

5.43

7.29

mmol/l

—

Inflammatory bowel disease treatment related agents

846

5127

0.92

1.52

1.3

7.25

7.00

mmol/l

1.73

769

4545

Chronic kidney disease

1090

0.78

1.52

1.2

8.51

7.75

mmol/l

1.28

913

337

2949

1.14

1.51

1.4

7.13

6.99

mmol/l

0.38

301

2625

Diseases of the ear and mastoid process

1010

4703

1.08

1.51

1.3

1.4

7.12

6.98

mmol/l

0.85

897

4217

Exposure to other specified electric current

128

0.39

1.50

1.6

1.4

6.74

7.23

mmol/l

—

114

Major coronary heart disease event excluding revascularizations

321

1876

1.14

1.50

1.2

7.74

7.62

mmol/l

0.26

268

1604

Endocarditis

127

0.39

1.50

1.2

1.3

8.42

7.65

mmol/l

—

112

Other and unspecified disorders of vitreous body

225

1904

1.17

1.49

1.3

1.2

7.24

7.64

mmol/l

1.35

189

1645

Congenital malformations of the urinary system

269

0.55

1.49

1.4

7.11

7.08

mmol/l

0.02

239

Other deformities of toe(s)

128

0.39

1.49

1.0

1.4

9.36

7.24

mmol/l

—

112

Infections of breast associated with childbirth

334

1.42

1.49

1.7

1.6

6.17

6.63

mmol/l

1.18

307

Use of memantine

591

0.73

1.49

1.2

7.98

8.06

mmol/l

0.07

455

Use of other anti-dementia drugs

591

0.73

1.49

1.2

7.98

8.06

mmol/l

0.07

455

Crushed, pushed or stepped on by crowd or human stampede

405

0.64

1.49

1.4

6.60

6.80

mmol/l

0.22

367

Acute renal failure

826

0.75

1.49

1.3

1.2

8.91

7.68

mmol/l

2.38

696

Disorders of mineral metabolism

325

1.42

1.49

1.2

1.3

7.45

7.25

mmol/l

0.20

290

Fracture of forearm

312

3245

0.88

1.48

1.3

6.70

7.15

mmol/l

2.58

277

2888

Diaphragmatic hernia

196

1665

1.18

1.48

1.3

1.2

7.38

7.60

mmol/l

0.61

177

1421

Other chronic obstructive pulmonary disease

148

1469

0.83

1.48

1.3

1.2

7.74

7.67

mmol/l

0.11

129

1236

Other symptoms and signs involving the digestive system and abdomen

113

911

1.24

1.47

1.3

7.30

7.24

mmol/l

0.08

107

812

Special screening examination for infectious and parasitic diseases

191

1656

0.85

1.47

1.4

6.71

6.65

mmol/l

0.11

182

1522

Spirochaetal infections, other/unspecified

367

0.62

1.46

1.2

1.3

6.23

7.39

mmol/l

1.12

323

COPD (mode)

114

1106

0.81

1.46

1.3

1.2

7.81

7.50

mmol/l

0.49

100

921

Non-small cell lung cancer, including Hilmo

504

0.69

1.46

1.1

1.2

8.34

7.70

mmol/l

0.50

417

Female genital prolapse

205

983

1.18

1.46

1.2

1.3

7.37

7.14

mmol/l

0.53

179

867

All dysplastic lesions of the vulva

195

1.55

1.46

1.3

7.28

7.40

mmol/l

0.09

173

Vitreous haemorrhage

403

0.64

1.46

1.1

1.3

8.83

7.43

mmol/l

1.14

350

Nontoxic multinodular goitre

106

850

1.25

1.45

1.3

1.2

6.97

7.45

mmol/l

1.34

732

Medicines for HER+ breast cancer

163

1837

0.84

1.45

1.2

1.3

7.40

7.38

mmol/l

0.03

148

1606

Alcohol abuse, main dg, excluding more controls

957

0.77

1.44

1.3

7.64

7.04

mmol/l

0.75

862

Pollen allergy

117

1416

0.81

1.44

1.4

1.5

6.35

6.69

mmol/l

1.06

107

1295

Seropositive rheumatoid arthritis, strict definition

741

0.74

1.44

1.3

7.10

7.37

mmol/l

0.32

655

Mycoses

124

1511

0.82

1.44

1.2

1.3

7.01

7.26

mmol/l

0.50

107

1351

Other diseases of blood and blood-forming organs, wide

1113

0.79

1.43

1.3

7.72

7.40

mmol/l

0.40

987

Periodontitis

713

4380

1.09

1.43

1.3

7.43

7.18

mmol/l

1.39

607

3880

Caries of dentine

136

1091

1.22

1.43

1.3

7.29

7.24

mmol/l

0.06

113

942

Fall on same level involving ice and snow

404

3622

1.12

1.41

1.3

7.18

7.15

mmol/l

0.06

347

3214

Other viral diseases

179

2099

0.85

1.41

1.3

1.4

6.72

6.89

mmol/l

0.45

165

1894

N06DA Anticholinesterases

771

0.78

1.40

1.2

8.01

8.05

mmol/l

0.03

601

Use of anticholinesterases

771

0.78

1.40

1.2

8.01

8.05

mmol/l

0.03

601

Mycoses

579

5508

0.91

1.40

1.3

1.4

7.11

7.03

mmol/l

0.35

530

4889

Nasal polyp

114

927

1.23

1.39

1.2

7.59

7.41

mmol/l

0.26

812

Focal epilepsy, mode (most common among epilepsy diagnosis)

961

0.78

1.38

1.3

6.73

7.19

mmol/l

0.85

853

Immunodeficiency with predominantly antibody defects

121

0.41

1.38

1.2

1.4

5.76

7.30

mmol/l

—

102

Hodgkin lymphoma, hilmo

121

0.41

1.38

1.2

1.5

8.76

7.54

mmol/l

—

106

Other disorders of binocular movement

135

1.65

1.37

1.7

1.4

6.00

7.15

mmol/l

2.15

122

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

274

2407

1.14

1.36

1.5

1.4

7.10

6.72

mmol/l

1.59

258

2186

ILD medications

859

5016

0.93

1.36

1.4

1.3

7.25

6.99

mmol/l

1.88

778

4448

Other and unspecified disorders of pigmentation

0.00

1.35

0.0

1.3

—

7.06

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

1.35

0.0

1.3

—

7.35

—

Convulsions, not elsewhere classified

123

1470

0.82

1.35

1.3

1.4

7.25

7.03

mmol/l

0.30

114

1307

Coxarthrosis

286

1658

1.14

1.35

1.2

7.83

7.59

mmol/l

0.67

236

1436

Exfoliative dermatitis

0.00

1.35

0.0

1.2

—

7.74

—

Chronic periodontitis, including avohilmo

709

4378

1.09

1.35

1.3

7.43

7.18

mmol/l

1.32

603

3879

Benign paroxysmal vertigo

168

1423

1.18

1.35

1.3

7.15

7.49

mmol/l

0.84

145

1234

Hypermobility syndrome

392

1.36

1.35

1.3

1.5

6.90

6.85

mmol/l

0.05

357

Other antidepressants

857

4070

1.08

1.34

1.2

1.4

7.36

7.01

mmol/l

2.58

768

3598

Renal tubulo-interstitial disorders in diseases classified elsewhere

0.00

1.34

0.0

1.4

—

7.52

—

Diseases of external ear

166

1955

0.85

1.34

1.3

7.47

7.25

mmol/l

0.36

147

1725

Mood disorders, excluding more controls

792

4374

1.08

1.34

1.3

7.27

7.01

mmol/l

1.67

720

3864

Other and unspecified vascular occlusions

307

1.40

1.34

1.3

1.2

8.23

7.81

mmol/l

0.38

258

Focal epilepsy, strict definition

1001

0.79

1.33

1.3

7.04

7.24

mmol/l

0.21

888

Focal epilepsy

1134

0.80

1.33

1.3

6.98

7.22

mmol/l

0.30

1005

Phobic anxiety disorders

1088

0.80

1.33

1.3

1.5

7.37

6.62

mmol/l

1.72

997

Benign lipomatous neoplasm

178

1517

1.18

1.33

1.2

1.3

6.82

7.42

mmol/l

2.53

160

1321

Soft tissue disorders related to use, overuse and pressure

163

1379

1.18

1.33

1.2

8.09

7.48

mmol/l

1.72

142

1203

Injuries to the elbow and forearm

450

4365

0.90

1.32

1.3

1.4

6.87

7.07

mmol/l

0.90

398

3884

Sequelae of injuries of upper limb

471

1.32

1.3

7.32

7.19

mmol/l

0.14

420

Other congenital malformations of intestine

0.00

1.32

0.0

1.4

—

7.45

—

Selective serotonin reuptake inhibitors

841

4072

1.08

1.32

1.3

1.4

7.24

7.01

mmol/l

1.28

746

3600

Periapical abscess

317

2818

1.13

1.31

1.3

7.44

7.21

mmol/l

0.67

275

2502

Osteitis due to dental implant

2.53

1.31

1.3

1.2

9.00

7.80

mmol/l

—

Seropositive rheumatoid arthritis

103

1259

0.81

1.30

1.3

7.45

7.54

mmol/l

0.11

1093

Suggestive for eosinophilic asthma

403

1.34

1.30

1.2

1.3

7.54

7.25

mmol/l

0.29

350

Recurrent aphthous stomatitis , including avohilmo

747

1.25

1.29

1.4

6.78

7.11

mmol/l

0.55

676

Depression or dysthymia

550

2770

1.10

1.29

1.3

7.09

7.06

mmol/l

0.08

487

2422

Acute laryngitis and tracheitis

771

1.24

1.28

1.5

6.44

6.76

mmol/l

0.63

698

Aortic aneurysm

822

0.77

1.27

1.2

8.00

7.81

mmol/l

0.19

676

Emotionally unstable personality disorder

1082

0.80

1.27

1.4

1.5

6.90

6.68

mmol/l

0.39

990

Streptococcal septicaemia

353

0.65

1.27

1.2

1.3

8.17

7.38

mmol/l

0.45

298

Impingement syndrome of shoulder

139

1166

1.19

1.26

1.2

7.72

7.64

mmol/l

0.09

118

1018

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

633

0.74

1.26

1.2

10.15

7.59

mmol/l

3.54

551

Seronegative juvenile rheumatoid arthritis

117

0.42

1.26

1.6

1.5

5.96

6.74

mmol/l

—

105

Viral conjunctivitis

115

0.43

1.25

1.0

1.4

8.11

7.46

mmol/l

—

100

Diseases of tongue

244

1.44

1.25

1.2

1.3

6.34

7.28

mmol/l

1.56

209

Preparatory care for dialysis

159

0.50

1.25

1.1

1.3

8.04

7.25

mmol/l

—

138

Injuries to the thorax

218

2494

0.87

1.23

1.3

7.29

7.36

mmol/l

0.11

189

2174

Hypothermia

1.92

1.23

1.2

1.3

7.66

7.74

mmol/l

0.03

Paralytic ileus and intestinal obstruction

1133

0.81

1.23

1.3

1.2

7.26

7.68

mmol/l

0.84

972

Other noninfective gastroenteritis and colitis

114

1373

0.83

1.23

1.4

1.3

7.32

7.13

mmol/l

0.32

102

1219

Other functional intestinal disorders

289

2381

1.13

1.22

1.4

1.3

7.16

7.26

mmol/l

0.24

258

2094

Primary_lymphoid and hematopoietic malignant neoplasms

989

0.80

1.22

1.2

7.52

7.67

mmol/l

0.19

849

Occupant of special vehicle mainly used on industrial premises injured in transport accident

2.68

1.22

2.0

1.1

8.82

8.15

mmol/l

—

Erysipelas

396

3341

0.90

1.21

1.2

7.68

7.30

mmol/l

1.69

351

2905

Coxarthrosis, primary

297

2236

1.13

1.21

1.2

7.78

7.67

mmol/l

0.25

242

1912

Benign neoplasm: Conjunctiva

141

0.49

1.21

1.0

1.4

6.11

7.65

mmol/l

—

121

Ulcerative colitis (strict definition, require KELA)

1031

0.80

1.21

1.3

1.4

6.77

7.01

mmol/l

0.43

934

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.85

1.20

1.1

1.4

7.71

7.37

mmol/l

—

Other specific joint derangements/joint disorders

645

3850

1.08

1.19

1.3

1.4

7.12

6.88

mmol/l

1.31

588

3448

Polyarthropathies

423

3043

0.91

1.19

1.3

7.64

7.07

mmol/l

3.20

376

2695

Macular pucker

535

0.73

1.19

1.1

1.2

6.49

7.87

mmol/l

2.85

453

Complications of the puerperium, not elsewhere classified

341

1.36

1.19

1.5

6.88

6.79

mmol/l

0.10

316

Infections, IBD-co-morbidities

100

582

1.23

1.18

1.2

1.3

7.38

6.45

mmol/l

2.75

504

Retention of urine

118

1160

0.83

1.18

1.2

7.80

7.69

mmol/l

0.16

102

971

Alzheimer disease, excluding more controls

369

0.73

1.18

1.3

1.2

7.65

8.31

mmol/l

0.64

282

Migraine without aura

187

1620

1.16

1.17

1.5

6.51

6.64

mmol/l

0.33

175

1467

Malignant neoplasm of parotid gland

0.00

1.17

0.0

1.2

—

7.69

—

Other shoulder lesions

481

1.29

1.16

1.4

1.3

7.73

7.27

mmol/l

0.47

429

Type 1 diabetes, wide definition, subgroup 2

0.00

1.16

0.0

1.5

—

6.85

—

Cholecystitis

543

1.27

1.16

1.1

1.2

7.88

7.53

mmol/l

0.36

468

Lung transplant status

0.00

1.16

0.0

1.1

—

8.12

—

Lung transplantation

0.00

1.16

0.0

1.1

—

8.12

—

Disorders resulting from impaired renal tubular function

130

0.46

1.16

1.2

1.3

8.72

7.57

mmol/l

—

112

Right side

2.54

1.16

1.0

1.1

—

7.26

—

Malignant neoplasm of bone and articular cartilage

0.00

1.15

0.0

1.2

—

8.43

—

Pedal cyclist injured in noncollision transport accidents

611

0.75

1.15

1.3

1.4

6.89

7.03

mmol/l

0.12

553

Crystalline deposits in vitreous body

0.00

1.14

0.0

1.2

—

7.41

—

Misadventures to patients during surgical and medical care

724

1.23

1.13

1.2

1.3

7.16

7.30

mmol/l

0.18

647

Pulmonary heart disease, diseases of pulmonary circulation

118

1405

0.84

1.13

1.2

8.27

7.58

mmol/l

1.37

102

1215

Concussion

391

2894

1.10

1.13

1.4

7.15

6.90

mmol/l

1.17

350

2556

Other congenital malformations of circulatory system

111

0.45

1.13

1.0

1.4

8.74

7.26

mmol/l

—

Exposure to other and unspecified animate mechanical forces

183

0.54

1.12

1.3

1.4

6.46

7.17

mmol/l

—

161

Vasomotor rhinitis (mode)

327

1.35

1.12

1.2

1.3

7.19

7.46

mmol/l

0.22

287

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

401

0.70

1.12

1.4

7.22

6.79

mmol/l

0.36

363

Other obstructive and reflux uropathy

233

0.60

1.12

1.3

1.4

5.77

6.99

mmol/l

3.50

209

Injuries to the hip and thigh

212

2184

0.88

1.12

1.3

7.34

7.40

mmol/l

0.12

192

1874

Chronic ulcer of skin, not elsewhere classified

233

0.60

1.11

1.1

1.3

9.34

7.62

mmol/l

0.53

198

Nontoxic goitre/thyroid nodule

165

1424

1.16

1.10

1.3

7.17

7.44

mmol/l

0.65

148

1241

Mucosal proctocolitis

764

0.78

1.10

1.3

1.4

6.77

7.01

mmol/l

0.34

694

Specific personality disorders

166

1917

0.86

1.10

1.4

7.22

6.78

mmol/l

1.36

155

1737

Contusion of toe(s) without damage to nail

138

0.50

1.10

1.9

1.5

6.30

7.05

mmol/l

—

122

Other abortion

1.97

1.09

1.7

1.3

5.86

7.14

mmol/l

—

Other/unspecified synovitis and tenosynovitis

575

1.26

1.09

1.5

1.3

7.39

7.37

mmol/l

0.02

504

Increased muscle tone

2.22

1.09

1.1

1.4

6.56

7.65

mmol/l

—

Asthma-related infections

414

3701

1.10

1.08

1.4

1.3

7.26

7.04

mmol/l

0.76

369

3265

Asthma, hospital admission 2, infections

414

3701

1.10

1.08

1.4

1.3

7.26

7.04

mmol/l

0.76

369

3265

Spermatocele

252

1.39

1.08

1.1

1.2

7.19

7.65

mmol/l

0.52

219

Valvular heart disease excluding rheumatic fever

212

1739

0.88

1.08

1.2

7.43

7.48

mmol/l

0.09

187

1487

Open wound of head

274

2948

0.89

1.07

1.2

1.3

7.16

7.35

mmol/l

0.45

234

2569

ILD medications: azathioprine

916

0.81

1.07

1.4

7.03

7.00

mmol/l

0.04

819

Suppurative and necrotic conditions of lower respiratory tract

193

0.57

1.07

1.2

1.3

6.82

7.48

mmol/l

0.48

168

Postviral fatigue syndrome

1.95

1.07

1.2

1.6

7.08

7.43

mmol/l

—

Non-rheumatic valve diseases

211

1728

0.88

1.06

1.2

7.45

7.47

mmol/l

0.02

185

1476

Azathioprine

915

0.81

1.06

1.4

7.03

mmol/l

0.00

819

Malignant neoplasm of bladder, including Hilmo

370

0.70

1.05

1.1

1.2

8.07

7.82

mmol/l

0.15

295

Generalized skin eruption due to drugs and medicaments

179

0.56

1.05

1.0

1.4

6.75

7.49

mmol/l

—

156

Benign neoplasm of brain and other parts of central nervous system

271

1.37

1.04

1.2

1.3

6.98

7.42

mmol/l

0.48

237

Use of selegiline

125

0.48

1.04

1.2

7.50

7.57

mmol/l

—

105

Ankylosing hyperostosis [Forestier]

1.97

1.04

1.1

1.2

8.10

7.98

mmol/l

—

Benign neoplasm of breast

634

0.77

1.04

1.3

6.39

7.28

mmol/l

1.77

565

Urolithiasis

179

1564

1.15

1.03

1.3

1.2

7.76

7.44

mmol/l

0.76

156

1358

Pyothorax

150

0.53

1.03

1.3

1.2

6.66

7.44

mmol/l

—

130

Atypical facial pain

238

1.39

1.02

1.3

7.03

7.49

mmol/l

0.40

209

Sensorineural hearing loss

448

2790

1.09

1.02

1.2

7.73

7.43

mmol/l

1.20

366

2444

Calculus of lower urinary tract

171

1.47

1.02

1.2

1.3

7.43

7.45

mmol/l

0.01

145

Myocardial infarction, unclassifiable

595

0.78

1.02

1.1

1.2

8.82

7.87

mmol/l

1.13

485

Injury of muscle and tendon at hip and thigh level

456

1.28

1.02

1.2

1.3

6.89

7.39

mmol/l

0.92

401

Alcohol dependence

119

1399

0.85

1.01

1.3

1.2

7.76

7.34

mmol/l

0.68

107

1232

Alcohol abuse, main dg

909

0.81

1.01

1.3

7.64

7.10

mmol/l

0.64

817

Excessive attrition of teeth

456

4199

1.09

1.01

1.3

1.4

7.00

6.95

mmol/l

0.14

410

3763

Impacted teeth

207

1627

1.13

1.01

1.4

1.6

6.26

6.46

mmol/l

0.75

190

1495

Glaucoma suspect

183

1605

1.14

1.00

1.2

7.86

7.61

mmol/l

0.53

170

1365

Mental and behavioural disorders due to opioids

201

0.59

1.00

1.0

1.4

7.78

6.93

mmol/l

0.36

180

Internal derangement of knee

212

2377

0.89

1.00

1.3

7.13

7.17

mmol/l

0.07

191

2097

Papulosquamous disorders

249

2228

1.12

0.99

1.3

7.80

7.32

mmol/l

1.52

212

1967

Optic neuritis

249

0.64

0.99

1.3

1.4

6.25

7.10

mmol/l

0.79

220

LeFortI or BSSO operation

257

1.37

0.99

1.3

1.4

6.48

7.03

mmol/l

0.63

236

Mandibular retrognathia AND surgery (BSSO)

156

1.49

0.99

1.2

1.4

6.48

7.21

mmol/l

0.76

142

Fibroblastic disorders

119

1012

1.18

0.99

1.2

7.49

7.71

mmol/l

0.33

107

866

Ménière disease

361

1.31

0.99

1.2

1.3

7.73

7.59

mmol/l

0.11

307

Retinal vascular occlusion

405

1.29

0.98

1.3

8.15

7.69

mmol/l

0.50

337

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

993

0.82

0.98

1.3

1.4

6.79

6.98

mmol/l

0.31

897

Suicide or other Intentional self-harm

149

1716

0.87

0.98

1.3

1.4

7.60

6.95

mmol/l

1.83

141

1544

Malignant neoplasm of base of tongue

0.00

0.98

0.0

1.1

—

8.17

—

Hernia of abdominal wall, postoperative

120

1022

1.18

0.98

1.3

7.17

7.40

mmol/l

0.36

101

864

Acute and transient psychotic disorders

638

1.23

0.98

1.3

8.54

7.06

mmol/l

2.99

573

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.98

0.0

1.1

—

8.71

—

Colectomy operation

662

0.78

0.98

1.2

7.97

7.58

mmol/l

0.42

569

Other diseases of the digestive system

118

1383

0.85

0.98

1.2

7.73

7.53

mmol/l

0.29

1191

Haemangioma, any site

388

1.29

0.98

1.5

1.3

7.55

7.30

mmol/l

0.21

344

Disorders of thyroid, IBD co-morbidities

155

944

1.16

0.97

1.4

1.5

6.52

6.25

mmol/l

0.73

140

842

Heterophoria

477

1.26

0.97

1.4

7.29

6.95

mmol/l

0.44

431

Injury of cranial nerves

0.00

0.97

0.0

1.4

—

7.70

—

Peripheral artery operations in Hilmo

400

0.72

0.96

1.1

1.2

8.33

7.70

mmol/l

0.51

332

Juvenile cataract

0.00

0.96

0.0

1.2

—

8.12

—

Embedded and impacted teeth

282

2100

1.11

0.96

1.5

1.6

6.32

6.46

mmol/l

0.57

256

1929

Conductive and sensorineural hearing loss

488

3043

1.08

0.96

1.2

1.3

7.72

7.37

mmol/l

1.59

402

2677

Exposure to excessive heat of man-made origin

0.00

0.95

0.0

1.3

—

7.31

—

Disorders of adult personality and behaviour

209

2348

0.89

0.95

1.4

7.11

6.77

mmol/l

1.17

195

2127

Later onset COPD, excluding more controls

519

0.79

0.95

1.2

8.20

7.91

mmol/l

0.32

400

Cauda equina syndrome

1.79

0.95

1.5

6.77

7.68

mmol/l

0.83

Poisoning by medicine, drug-induced

1.79

0.95

1.3

1.4

8.37

7.67

mmol/l

0.36

Childhood asthma (age<16)

146

997

1.16

0.95

1.7

1.5

6.22

6.38

mmol/l

0.46

138

904

HSIL lesion of the vagina

1.79

0.95

1.4

1.5

7.74

7.05

mmol/l

0.32

Artificial joint operation, meniscal resection

576

3479

1.08

0.95

1.2

7.27

7.43

mmol/l

0.69

512

3027

Androgenic alopecia

1.91

0.94

1.3

1.5

6.80

7.00

mmol/l

—

Acquired absence of limb

1.91

0.94

1.0

1.2

8.19

7.17

mmol/l

—

Benign neoplasm: Brain, unspecified

2.25

0.94

1.0

1.1

6.30

7.95

mmol/l

—

Other and unspecified iron deficiency

160

1825

0.87

0.94

1.4

1.3

6.94

7.31

mmol/l

0.97

142

1602

Gout

118

886

1.17

0.94

1.2

8.45

7.78

mmol/l

1.47

102

746

Acute generalized exanthematous pustulosis

197

0.61

0.94

1.0

1.4

6.92

7.44

mmol/l

0.44

170

In situ neoplasms

190

2144

0.89

0.93

1.3

1.4

7.72

7.25

mmol/l

1.05

165

1886

Spasmodic torticollis

143

0.56

0.93

1.1

1.4

6.77

7.40

mmol/l

—

122

Oral corticosteroids

779

4910

0.94

0.93

1.3

7.31

7.03

mmol/l

1.85

709

4344

Hypermetropia

329

1.31

0.93

1.6

1.4

6.60

6.99

mmol/l

0.50

295

Heartburn

606

1.22

0.93

1.2

1.3

6.94

7.07

mmol/l

0.14

538

Childhood asthma (age<16), excluding more controls

146

998

1.16

0.93

1.7

1.5

6.22

6.37

mmol/l

0.43

138

903

Other anxiety disorders

369

3486

0.92

0.93

1.4

6.76

6.79

mmol/l

0.07

343

3174

Mental and behavioural disorders due to use of other stimulants, including caffeine

146

0.54

0.93

1.1

1.4

6.26

7.16

mmol/l

—

133

GI-bleeding

118

1375

0.86

0.93

1.2

7.68

7.56

mmol/l

0.15

1181

Retinal vascular disorders

409

1.27

0.92

1.3

8.15

7.70

mmol/l

0.50

339

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

482

1.25

0.92

1.4

1.5

6.32

6.68

mmol/l

0.64

442

Viral pneumonia (unknown virus, not influenza)

327

0.70

0.92

1.3

6.08

7.13

mmol/l

1.88

291

Stroke, including SAH

268

2152

0.90

0.92

1.3

1.2

7.75

7.65

mmol/l

0.18

230

1827

Abscess of Bartholin gland

183

0.60

0.91

1.3

1.5

6.49

6.85

mmol/l

0.17

165

Other viral diseases, not elsewhere classified

1121

0.84

0.91

1.3

1.4

6.84

6.97

mmol/l

0.20

1012

Plantar fascial fibromatosis

473

1.25

0.91

1.3

1.2

7.09

7.38

mmol/l

0.40

410

Acute gastritis

296

1.32

0.90

1.3

7.15

7.47

mmol/l

0.20

258

Bilateral sagittal split ramus osteotomy operation

210

1.39

0.90

1.2

1.4

6.64

7.05

mmol/l

0.34

189

Viral conjunctivitis

207

0.62

0.90

1.7

1.4

7.66

7.14

mmol/l

0.20

182

Postmenopausal bleeding

140

645

1.16

0.90

1.2

7.82

7.53

mmol/l

0.49

111

556

Intestinal infectious diseases

921

4977

1.06

0.90

1.3

7.09

7.06

mmol/l

0.12

832

4409

Lesion of plantar nerve

236

1.36

0.89

1.3

7.03

7.66

mmol/l

0.59

205

Gout, idiopatic and unspecified

105

893

1.18

0.89

1.2

8.54

7.72

mmol/l

1.80

747

Cardiomyopathy

719

0.81

0.89

1.1

1.2

8.08

7.58

mmol/l

0.58

606

Injury of muscle and tendon at shoulder and upper arm level

196

1744

1.13

0.89

1.2

7.45

7.59

mmol/l

0.25

166

1504

Superficial injury of head

114

1326

0.86

0.89

1.3

7.07

7.19

mmol/l

0.21

101

1173

Haemorrhage from respiratory passages

179

1427

1.13

0.89

1.2

1.3

7.59

7.45

mmol/l

0.25

153

1231

Symptoms and signs involving the nervous and musculoskeletal systems

385

3545

1.09

0.88

1.3

7.21

7.19

mmol/l

0.02

345

3113

Chronic hepatitis NAS

1.80

0.88

1.5

1.3

8.02

7.34

mmol/l

—

Chalazion

620

1.21

0.88

1.4

6.32

7.16

mmol/l

2.64

557

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

783

0.82

0.88

1.1

1.2

8.72

7.67

mmol/l

1.52

658

Malignant neoplasm of prostate

104

731

0.85

0.87

1.2

1.1

7.27

7.67

mmol/l

0.64

614

Medical observation and evaluation for suspected diseases and conditions

513

2438

1.08

0.87

1.3

7.13

6.94

mmol/l

0.76

449

2173

Pulmonary embolism

112

1301

0.86

1.2

8.35

7.56

mmol/l

1.58

1135

Benign neoplasm of colon, rectum, anus and anal canal

337

2681

1.09

0.86

1.2

7.49

7.59

mmol/l

0.23

277

2322

Fracture at wrist and hand level

192

2147

0.89

0.86

1.3

6.99

7.09

mmol/l

0.18

177

1921

Pacemaker

1072

0.85

0.86

1.1

1.2

7.86

7.95

mmol/l

0.09

875

Secondary uncertain malignant neoplasm

493

0.77

0.86

1.2

1.3

8.41

7.62

mmol/l

0.67

413

Other disorders of fluid, electrolyte and acid-base balance

113

1249

0.86

1.2

8.41

7.54

mmol/l

2.42

100

1070

Irritable bowel syndrome

207

1854

1.12

0.85

1.4

6.79

7.05

mmol/l

0.69

192

1664

Calculus of kidney and ureter

165

1458

1.13

0.85

1.3

1.2

7.78

7.41

mmol/l

0.95

148

1271

Pulmonary heart disease

112

1299

0.86

0.85

1.2

8.35

7.55

mmol/l

1.59

1134

Opioids

880

4327

1.06

0.85

1.3

1.4

7.26

6.90

mmol/l

3.02

808

3826

Other renal tubulo-interstitial diseases

104

1.55

0.85

1.2

1.4

7.64

7.34

mmol/l

0.17

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

168

1487

1.13

0.85

1.3

1.2

9.59

6.64

mmol/l

16.00

141

1324

Glucagon-like peptide-1 (GLP-1) analogues

168

1487

1.13

0.85

1.3

1.2

9.59

6.64

mmol/l

16.00

141

1324

Other complications of labour and delivery, not elsewhere classified

129

1029

1.15

0.84

1.7

1.5

6.33

6.42

mmol/l

0.18

118

947

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

826

1.18

0.84

1.7

1.5

6.44

6.63

mmol/l

0.38

755

Benign neoplasm of other and unspecified endocrine glands

596

1.21

0.84

1.3

7.76

7.35

mmol/l

0.57

530

Other disorders of veins

206

2281

0.90

0.84

1.3

7.12

7.36

mmol/l

0.60

173

2017

Thyrotoxicosis with diffuse goitre

101

863

1.17

0.83

1.4

6.71

6.96

mmol/l

0.47

770

Stroke, excluding SAH

246

1983

0.90

0.83

1.3

1.2

7.82

7.66

mmol/l

0.29

209

1678

Procedures for purposes other than remedying health state

114

0.52

0.83

1.0

1.4

6.47

7.53

mmol/l

—

Hereditary deficiency of other clotting factors

1.76

0.83

1.6

1.5

7.00

7.40

mmol/l

—

Other bursopathies

597

1.21

0.83

1.3

1.2

6.40

7.55

mmol/l

4.28

516

Asthma, unspecified (mode), excluding more controls

399

2760

1.08

0.83

1.3

7.42

7.00

mmol/l

2.02

358

2395

Unspecified mental disorder

305

2792

1.09

0.82

1.3

1.4

7.86

7.00

mmol/l

5.15

272

2504

Other symptoms and signs involving cognitive functions and awareness

245

2020

1.11

0.82

1.2

1.3

7.15

7.56

mmol/l

1.57

222

1744

Early lumbar disc prolapse, operated

699

1.19

0.82

1.3

1.4

6.90

6.93

mmol/l

0.02

639

Codeine or tramadol medication

940

4885

1.05

0.81

1.3

1.4

7.34

6.97

mmol/l

3.26

848

4326

Other maltreatment syndromes

155

1.43

0.81

1.5

1.3

7.05

7.48

mmol/l

0.29

138

Subacute thyroiditis

172

1.40

0.81

1.5

1.3

5.96

7.24

mmol/l

1.98

147

Congenital malformations of eye, ear, face and neck

382

1.26

0.81

1.4

1.5

7.37

6.83

mmol/l

0.63

346

Malignant neoplasm of prostate, including Hilmo

111

765

0.86

0.81

1.2

1.1

7.21

7.64

mmol/l

0.78

645

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

169

1689

0.89

0.80

1.5

1.6

7.04

6.42

mmol/l

2.03

161

1559

Endovascular or surgical operations to intracerebral aneurysms

248

0.68

0.80

1.3

1.2

7.88

7.55

mmol/l

0.13

216

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

951

0.85

0.80

1.2

1.4

7.12

7.04

mmol/l

0.08

854

Otitis externa

116

1334

0.87

0.80

1.4

1.3

7.65

7.10

mmol/l

0.95

104

1191

Exposure to ignition of highly flammable material

0.00

0.79

0.0

1.1

—

8.03

—

Disorders of other and unspecified cranial nerves

0.00

0.79

0.0

1.2

—

7.28

—

Mental and behavioural disorders due to hallucinogens

0.00

0.79

0.0

1.3

—

7.40

—

Haemangioma and lymphangioma, any site

419

1.24

0.79

1.5

1.3

7.47

7.27

mmol/l

0.17

374

Acute suppurative otitis media

196

2034

0.90

0.79

1.5

6.97

6.62

mmol/l

0.76

184

1858

Trochanteric bursitis

637

1.20

0.79

1.2

8.17

7.64

mmol/l

0.76

550

Diagnoses used for exclusion with ILD

1151

0.86

0.79

1.2

7.51

7.56

mmol/l

0.05

1000

Asthma, unspecified (mode)

403

2814

1.08

0.79

1.3

7.42

7.03

mmol/l

1.80

360

2441

Certolizumab pegol

131

1.46

0.79

1.9

1.6

6.25

6.86

mmol/l

0.75

115

Abnormal findings on diagnostic imaging of lung

197

2099

0.90

0.79

1.2

7.45

7.67

mmol/l

0.43

171

1795

Deviated nasal septum

199

1788

1.11

0.78

1.2

7.29

7.37

mmol/l

0.11

180

1561

Malignant neoplasm of rectosigmoid junction, including Hilmo

0.52

0.78

1.2

8.30

8.00

mmol/l

—

Bronchitis, not specified as acute or chronic

366

1.26

0.78

1.3

7.09

7.18

mmol/l

0.08

319

Chronic apical periodontitis

917

4966

1.05

0.78

1.4

1.3

7.26

6.98

mmol/l

1.87

815

4426

Melanoma in situ of lower limb, including hip

0.00

0.78

0.0

1.1

—

7.35

—

Leiomyosarcoma

0.00

0.78

0.0

1.1

—

6.97

—

Endometriosis

284

1820

0.91

0.77

1.3

1.5

7.02

6.66

mmol/l

1.81

255

1646

Adenocarcinoma and ductal carcinoma of pancreas

100

0.50

0.77

1.2

8.75

7.64

mmol/l

—

Pediculosis, acariasis and other infestations

122

1066

1.15

0.77

1.3

1.4

6.75

6.85

mmol/l

0.16

113

968

Symptoms and signs involving speech and voice

162

1817

0.89

0.77

1.3

7.04

7.37

mmol/l

0.95

148

1598

Myocardial infarction, strict

219

1408

1.11

0.77

1.2

7.97

7.72

mmol/l

0.54

179

1197

Injury of nerves and spinal cord at thorax level

0.00

0.76

0.0

1.1

—

8.01

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

274

2498

1.09

0.76

1.5

7.10

6.65

mmol/l

2.12

258

2257

Triptan medication for migraine, min. 3 purchases

541

3875

1.07

0.76

1.4

6.80

6.78

mmol/l

0.08

502

3521

Hypopituitarism

305

1.28

0.76

1.3

7.53

7.08

mmol/l

0.39

274

Other disorders of breast and lactation associated with childbirth

173

0.63

0.76

1.5

1.6

6.82

6.66

mmol/l

0.09

158

Polyp of the female genital tract

194

1240

0.90

0.76

1.3

1.4

7.37

6.95

mmol/l

1.35

172

1105

Other diseases of intestines

896

4848

1.05

0.75

1.3

1.4

7.13

6.98

mmol/l

0.77

795

4341

Osteoporosis with pathological fracture (FG)

209

0.67

0.75

1.1

1.2

6.87

7.97

mmol/l

—

171

Benign leiomyoma with endometriosis

724

0.83

0.75

1.2

1.3

7.44

7.54

mmol/l

0.10

625

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

221

2402

0.91

0.74

1.4

1.5

7.00

6.63

mmol/l

1.36

203

2191

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

681

4123

1.06

0.74

1.3

7.23

7.24

mmol/l

0.03

597

3634

Juvenile rheumatoid arthirtis

134

0.59

0.73

1.1

1.4

5.63

7.01

mmol/l

—

121

Other extrapyramidal and movement disorders in other diseases

101

1164

0.87

0.73

1.3

7.35

7.46

mmol/l

0.14

1020

Other and unspecified nonorganic psychotic disorders

143

1268

1.13

0.73

1.3

1.4

8.14

6.88

mmol/l

4.60

135

1150

Other chronic obstructive pulmonary disease, including avohilmo

222

2018

0.91

0.73

1.3

1.2

7.77

7.68

mmol/l

0.19

194

1717

Cystic kidney disease

134

0.59

0.73

1.5

1.4

7.20

7.27

mmol/l

—

117

Other and unspecified rosacea

415

1.23

0.73

1.3

7.54

7.42

mmol/l

0.07

369

Striking against or struck by other objects

195

2154

0.90

0.73

1.3

6.97

7.03

mmol/l

0.12

170

1941

Nonsuppurative otitis media

172

1657

0.90

0.72

1.6

1.5

6.77

6.55

mmol/l

0.56

158

1511

Calcaneal spur

1.62

0.72

1.3

1.2

8.99

7.68

mmol/l

—

Other and unspecified effects of external causes

216

1962

1.10

0.72

1.4

7.22

6.88

mmol/l

0.95

196

1767

Melanocytic naevi of trunk

699

0.83

0.72

1.3

1.4

6.86

7.09

mmol/l

0.23

632

Codeine

829

4283

1.05

0.72

1.4

7.32

6.91

mmol/l

3.73

747

3783

Myocardial infarction, with ST-elevation

598

1.19

0.72

1.3

1.2

7.91

7.88

mmol/l

0.03

502

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

443

1.22

0.72

1.2

1.3

8.32

7.43

mmol/l

0.96

392

Viral warts

567

0.81

0.72

1.4

6.75

6.98

mmol/l

0.27

515

Presence of cardiac and vascular implants and grafts

204

1371

1.11

0.72

1.1

1.2

8.03

7.72

mmol/l

0.58

166

1149

malignant neoplasm of male genital organs

111

775

0.87

0.72

1.2

1.1

7.35

7.62

mmol/l

0.39

654

Pityriasis rosea

1.77

0.71

1.1

1.7

8.69

7.32

mmol/l

—

Other diseases of lip and oral mucosa

217

2384

0.91

0.71

1.2

1.3

7.40

7.31

mmol/l

0.14

190

2117

Cerebral palsy and other paralytic syndromes

507

1.21

0.71

1.3

7.26

7.16

mmol/l

0.10

451

Alcohol-induced chronic pancreatitis

264

0.72

0.71

1.2

9.67

7.45

mmol/l

1.35

232

Contact with sharp glass

229

0.70

0.71

1.2

1.4

6.72

7.05

mmol/l

0.21

203

FESS (DNB20)

686

0.83

0.71

1.3

7.85

7.22

mmol/l

0.38

612

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

710

4869

0.95

0.71

1.3

7.31

7.00

mmol/l

2.03

627

4333

Other disorders of skin and subcutaneous tissue, not elsewhere classified

653

0.83

0.70

1.1

1.3

7.26

7.37

mmol/l

0.07

567

Xanthelasma of eyelid

1.72

0.70

1.0

1.2

8.54

7.42

mmol/l

—

Assault by other specified means

1.56

0.70

1.1

1.4

7.82

7.77

mmol/l

—

Galactorrhea

1.56

0.70

1.6

7.91

6.89

mmol/l

—

Nutritional anaemias

240

2526

0.91

0.70

1.3

7.24

7.30

mmol/l

0.12

207

2197

Seborrhoeic keratosis

966

0.86

0.70

1.1

1.2

7.04

7.71

mmol/l

1.64

827

Hydrocele

372

1.24

0.70

1.2

1.1

6.83

7.68

mmol/l

1.14

322

Oter anti-inflammatory and antirheumatic agents, non-steroids

115

554

1.15

0.70

1.2

7.43

mmol/l

0.00

457

Chronic conjunctivitis

145

0.62

0.69

1.2

1.4

7.30

7.36

mmol/l

—

125

Myopia

879

0.85

0.69

1.4

6.88

6.86

mmol/l

0.02

797

Personality disorders, excluding more controls

201

2211

0.91

0.69

1.4

7.23

6.72

mmol/l

2.01

187

1997

Other and unspecified psoriasis

283

1.28

0.69

1.4

1.3

7.89

7.38

mmol/l

0.37

250

Purpura and other haemorrhagic conditions

630

0.82

0.69

1.4

1.3

7.04

7.31

mmol/l

0.30

554

Malignant melanoma of skin, including Hilmo

608

0.82

0.69

1.2

7.50

7.61

mmol/l

0.10

518

Scabies

105

917

1.15

0.69

1.3

1.4

6.67

6.83

mmol/l

0.26

832

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

239

1.30

0.69

1.2

1.3

7.91

7.18

mmol/l

0.71

210

Lichen planus, including avohilmo

102

889

1.15

0.69

1.2

7.82

7.46

mmol/l

0.46

787

Undetermined asthma, excluding more controls

703

1.17

0.68

1.3

7.28

7.03

mmol/l

0.39

615

Other and unspecified visual disturbances

501

1.20

0.68

1.4

1.3

6.99

7.19

mmol/l

0.26

443

Depression medications

314

1458

1.08

0.68

1.4

1.5

6.88

6.15

mmol/l

4.36

286

1312

Other complications of surgical and medical care, not elsewhere classified

492

1.20

0.68

1.4

1.3

6.95

7.24

mmol/l

0.48

441

Other and unspecified injuries of lower leg

401

1.23

0.68

1.4

7.01

6.99

mmol/l

0.01

360

Conductive hearing loss, unspecified

392

1.23

0.68

1.3

7.53

7.20

mmol/l

0.28

352

Molar incisor enamel hypoplasia

162

0.65

0.68

1.8

1.6

7.09

6.74

mmol/l

0.19

147

Collagenous colitis

408

0.78

0.68

1.2

1.3

7.24

7.36

mmol/l

0.11

361

Malignant neoplasm of oesophagus, including Hilmo

120

0.58

0.67

1.0

1.2

6.53

7.81

mmol/l

—

103

Open wound of abdomen, lower back and pelvis

156

0.64

0.67

1.3

1.4

5.96

7.25

mmol/l

—

139

Disorder of the sleep-wake schedule

0.54

0.67

1.4

1.5

6.16

6.98

mmol/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

0.55

0.67

1.4

1.6

6.68

6.96

mmol/l

—

Status epilepticus

121

0.58

0.67

1.3

7.27

7.11

mmol/l

—

110

Burn and corrosion of head and neck

0.55

0.67

1.4

7.52

7.72

mmol/l

—

Other noninflammatory disorders of uterus, except cervix

117

693

1.14

0.67

1.2

1.3

7.54

7.46

mmol/l

0.11

101

603

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

106

1206

0.88

0.66

1.4

7.44

6.87

mmol/l

1.36

1097

Other predominantly sexually transmitted diseases, not elsewhere classified

162

1797

0.90

0.66

1.5

6.99

6.61

mmol/l

1.08

155

1641

Arteriovenous malformation of peripheral vessels

1.81

0.66

1.8

1.5

6.84

7.75

mmol/l

—

Atopic dermatitis, strict definition

266

2402

1.09

0.66

1.5

6.75

6.66

mmol/l

0.24

249

2187

Retinoschisis and retinal cysts

1.52

0.66

1.1

1.2

8.49

7.27

mmol/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

329

3164

0.93

0.66

1.2

7.41

7.43

mmol/l

0.05

286

2750

Ulcerative enterocolitis

155

0.64

0.66

1.5

1.4

7.52

7.21

mmol/l

—

135

Lichen ruber planus, wide definition including periferal and oral lichen planus

122

1081

1.13

0.66

1.2

7.67

7.43

mmol/l

0.33

107

951

Other disorders of cornea

412

1.22

0.65

1.4

1.3

7.40

mmol/l

0.00

362

Other disorders of eye and adnexa

800

1.15

0.65

1.3

1.4

7.04

7.05

mmol/l

0.02

721

Other viral diseases

274

2940

0.92

0.65

1.4

6.75

6.82

mmol/l

0.20

254

2649

Traumatic subdural haemorrhage

421

0.80

0.65

1.3

1.2

7.68

8.00

mmol/l

0.27

339

Myocardial infarction

237

1528

1.09

0.65

1.2

7.95

7.68

mmol/l

0.69

193

1304

Kela-code for severe mental illness

261

2408

1.09

0.65

1.3

7.99

7.04

mmol/l

5.33

240

2158

Venous thromboembolism

254

2660

0.92

0.64

1.3

7.62

7.43

mmol/l

0.43

225

2286

Infections of the skin and subcutaneous tissue

422

3924

1.07

0.64

1.4

1.3

7.28

7.07

mmol/l

0.75

385

3473

Early onset COPD

1054

0.87

0.64

1.4

1.2

7.52

7.57

mmol/l

0.06

923

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

876

0.86

0.64

1.2

1.4

6.98

7.00

mmol/l

0.02

787

Cystitis

645

4037

0.95

0.64

1.3

1.4

7.06

6.95

mmol/l

0.50

597

3582

Zoster [herpes zoster]

284

2588

1.08

0.64

1.3

7.37

mmol/l

0.00

255

2247

Other diseases of liver

107

942

1.14

0.64

1.3

7.81

7.29

mmol/l

0.93

832

Cervical root disorders

1.74

0.64

1.0

1.1

6.30

7.75

mmol/l

—

Hernia

653

4157

1.05

0.64

1.3

7.19

7.23

mmol/l

0.13

591

3659

Anxiety disorders

743

4935

1.05

0.64

1.4

1.3

7.02

6.99

mmol/l

0.08

673

4404

Hypoplasia of dental enamel , including avohilmo

149

0.65

0.63

1.9

1.6

7.03

6.79

mmol/l

—

136

Coagulation defects, purpura and other haemorrhagic conditions

1052

0.87

0.63

1.4

1.3

7.07

7.15

mmol/l

0.10

937

Acute pancreatitis (for exclusion)

924

0.86

0.63

1.3

1.2

8.11

7.51

mmol/l

0.89

813

Intracranial injury

354

3580

0.93

0.63

1.4

1.3

7.24

7.11

mmol/l

0.40

314

3153

Tongue abnormality

234

1.29

0.63

1.2

1.3

6.56

7.54

mmol/l

1.33

204

Personality disorders

201

2197

0.91

0.62

1.4

7.23

6.79

mmol/l

1.60

187

1989

Appendicitis, broad definition

579

4968

1.05

0.62

1.4

1.3

7.21

7.04

mmol/l

0.79

523

4427

Diseases of appendix

582

4977

1.05

0.62

1.4

1.3

7.22

7.04

mmol/l

0.84

526

4435

Embedded teeth, including avohilmo

748

1.15

0.62

1.6

6.56

6.60

mmol/l

0.06

684

Superficial injury of forearm

562

1.18

0.62

1.2

1.5

7.09

6.91

mmol/l

0.27

518

Biomechanical lesions, not elsewhere classified

211

0.71

0.62

1.3

6.65

7.45

mmol/l

0.86

184

Melanocytic naevi of upper limb, including shoulder

105

0.57

0.62

1.3

1.4

8.10

7.20

mmol/l

—

Vascular diseases of the intestine

105

0.57

0.61

1.0

1.3

7.47

7.34

mmol/l

—

Colorectal adenocarcinoma

726

0.85

0.61

1.2

8.12

7.73

mmol/l

0.43

598

Anaemias

221

1324

1.09

0.60

1.4

1.5

6.68

6.16

mmol/l

2.55

201

1189

Undetermined asthma

712

1.15

0.60

1.3

7.28

7.02

mmol/l

0.40

629

Malignant neoplasm of oropharynx, including Hilmo

0.00

0.60

0.0

1.1

—

7.63

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

0.60

0.0

1.2

—

7.56

—

Acute sinusitis

406

3535

1.06

0.60

1.4

7.05

6.95

mmol/l

0.29

369

3163

Hydronephrosis

518

1.18

0.60

1.4

1.3

7.50

7.47

mmol/l

0.02

451

Herpesviral [herpes simplex] infections

163

1794

0.91

0.60

1.4

6.94

6.91

mmol/l

0.05

144

1617

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.60

0.0

1.1

—

8.84

—

Other fall from one level to another

146

1317

1.11

0.59

1.3

1.4

7.12

7.05

mmol/l

0.10

133

1184

Schizophrenia or delusion

223

2054

1.09

0.59

1.3

8.11

7.02

mmol/l

5.73

206

1844

Neurotic, stress-related and somatoform disorders

736

4919

1.05

0.59

1.4

1.3

7.02

6.99

mmol/l

0.10

666

4394

Coxarthrosis [arthrosis of hip](FG)

295

1930

1.08

0.59

1.2

7.82

7.63

mmol/l

0.52

244

1659

Peripheral arterial reconstruction

520

0.83

0.59

1.2

8.12

7.93

mmol/l

0.15

427

Postpartum haemorrhage due to retained placenta

139

1540

0.90

0.59

1.5

1.6

6.50

6.47

mmol/l

0.07

130

1408

malignant neoplasm of female genital organs

635

0.84

0.59

1.1

1.3

8.43

7.52

mmol/l

1.01

538

Other proliferative retinopathy

0.00

0.58

0.0

1.2

—

8.09

—

Malignant neoplasm of floor of mouth

0.00

0.58

0.0

1.2

—

7.91

—

Hydrocephalus in other diseases

0.00

0.58

0.0

1.1

—

7.27

—

Hypertrophic disorders of skin

336

1.22

0.58

1.2

1.4

6.48

6.91

mmol/l

0.46

302

Malignant neoplasm of bladder

185

0.70

0.58

1.1

1.2

6.64

7.95

mmol/l

—

147

Post-traumatic stress disorder

788

0.86

0.58

1.5

7.49

6.60

mmol/l

1.63

724

Certain infectious and parasitic diseases

806

4215

0.96

0.58

1.3

1.4

7.14

6.99

mmol/l

0.78

735

3756

Unspecified lump in breast

866

1.13

0.58

1.4

1.3

7.16

7.22

mmol/l

0.06

762

Acute alcohol intoxication ICD-9

116

0.60

0.57

1.7

1.2

7.97

7.55

mmol/l

—

104

Dystonia

253

0.75

0.57

1.2

1.3

6.81

7.49

mmol/l

0.83

217

Fracture of lower leg, including ankle

322

3403

0.94

0.57

1.3

7.42

7.19

mmol/l

0.65

287

2997

Erysipelas

282

2677

0.93

0.57

1.2

7.75

7.40

mmol/l

1.05

245

2310

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

764

1.14

0.57

1.7

1.5

6.24

6.53

mmol/l

0.81

703

Ethmoidectomy

701

0.85

0.57

1.3

7.73

7.21

mmol/l

0.32

626

Benign neoplasm: Skin of trunk

167

1.32

0.57

1.3

1.4

7.55

7.39

mmol/l

0.07

147

Disorder of lipoprotein metabolism, unspecified

438

1.19

0.56

1.3

1.2

8.30

7.66

mmol/l

0.69

375

Other diseases caused by chlamydiae

0.58

0.56

1.8

1.5

5.64

7.34

mmol/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.58

0.56

1.4

1.3

7.28

7.21

mmol/l

—

Gout, strict definition

633

1.15

0.56

1.1

1.2

8.58

7.83

mmol/l

1.22

525

Other congenital malformations of the digestive system

171

0.69

0.56

1.7

1.5

5.75

7.26

mmol/l

2.54

152

Family history of malignant neoplasm

732

0.86

0.56

1.4

6.77

7.02

mmol/l

0.35

667

Dislocation, sprain and strain of joints and ligaments of elbow

347

1.21

0.56

1.4

7.97

7.04

mmol/l

0.91

314

Myalgia

169

1543

1.10

0.56

1.4

6.82

7.05

mmol/l

0.58

148

1382

Other congenital malformations of peripheral vascular system

1.55

0.56

1.8

1.5

8.32

7.13

mmol/l

—

Otalgia

393

1.20

0.56

1.4

6.84

7.13

mmol/l

0.40

356

Other disorders of breast

806

0.87

0.55

1.4

7.58

6.98

mmol/l

1.01

718

Presbycusis

317

1.22

0.55

1.2

8.70

7.94

mmol/l

0.58

252

Phlebitis and thrombophlebitis (not including DVT)

131

1182

1.11

0.55

1.4

1.2

6.81

7.41

mmol/l

2.00

116

1049

Atopic dermatitis

515

4009

1.05

0.55

1.5

1.4

6.51

6.89

mmol/l

3.46

470

3635

Vocal cord dysfunction

670

1.14

0.54

1.3

7.17

6.37

mmol/l

2.12

603

Embolic stroke

122

0.65

0.54

1.8

1.2

7.70

7.54

mmol/l

—

Duodenal ulcer

362

0.80

0.54

1.2

8.76

7.59

mmol/l

0.75

303

Complications following infusion, transfusion and therapeutic injection

1.51

0.54

1.3

9.41

7.62

mmol/l

—

Retinal breaks without detachment

751

0.86

0.54

1.1

1.2

6.63

7.57

mmol/l

2.44

658

Use of pramipexole

985

0.88

0.54

1.3

1.2

7.34

7.58

mmol/l

0.33

851

Malignant melanoma, including Hilmo

751

0.86

0.54

1.3

1.2

7.40

7.57

mmol/l

0.20

629

Disorders of sclera, cornea, iris and ciliary body

334

3553

0.94

0.54

1.4

1.3

7.04

7.16

mmol/l

0.39

298

3148

Contact with machinery

487

1.17

0.54

1.1

1.2

7.67

7.44

mmol/l

0.31

428

Lichen sclerosus et atrophicus

450

1.18

0.54

1.1

1.2

7.24

7.50

mmol/l

0.26

390

Other predominantly sexually transmitted diseases, not elsewhere classified

129

1426

0.90

0.54

1.5

7.14

6.70

mmol/l

1.04

122

1299

Injury of nerves at forearm level

1.46

0.53

1.3

1.4

7.07

7.32

mmol/l

—

Fissure and fistula of anal and rectal regions

152

1386

1.10

0.53

1.3

7.38

7.31

mmol/l

0.11

138

1225

Artificial opening status

204

0.73

0.53

1.3

7.48

7.62

mmol/l

0.06

171

Cervicalgia

127

1148

1.11

0.52

1.3

7.07

7.28

mmol/l

0.43

119

1006

Migraine without aura, drug-induced

1.44

0.52

1.3

1.5

8.01

7.13

mmol/l

—

Viral and other specified intestinal infections

208

2167

0.92

0.52

1.5

6.66

6.65

mmol/l

0.01

189

1962

Benign neoplasm of mouth and pharynx

470

1.17

0.52

1.3

7.67

7.35

mmol/l

0.31

417

Disorders of breast

380

3258

1.06

0.52

1.4

6.99

6.94

mmol/l

0.14

355

2910

Behavioural disorders, excluding more controls

134

0.67

0.52

1.2

1.5

8.22

6.61

mmol/l

—

125

Other heart diseases, wide

747

4382

1.04

0.52

1.2

1.3

7.19

7.03

mmol/l

0.83

679

3902

Benign neoplasm of ovary

875

0.88

0.52

1.3

6.74

7.41

mmol/l

1.76

763

Retinal detachments and breaks

178

1637

1.09

0.52

1.1

1.2

7.40

7.66

mmol/l

0.55

139

1395

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

327

3469

0.94

0.51

1.2

1.3

7.20

7.26

mmol/l

0.14

302

3036

Asthma and allergy

113

1003

1.11

0.51

1.5

1.4

6.29

6.65

mmol/l

0.82

106

894

Schizophrenia, schizotypal and delusional disorders

222

2061

1.08

0.51

1.3

8.13

7.02

mmol/l

5.90

205

1848

Disorders of other endocrine glands

306

2826

1.07

0.51

1.4

7.41

7.01

mmol/l

1.21

278

2510

Stomatitis and related lesions

125

1131

1.11

0.51

1.4

6.92

7.08

mmol/l

0.27

116

1013

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

434

1.18

0.51

1.4

7.13

7.23

mmol/l

0.08

387

Other disorders of ear

630

3945

1.05

0.51

1.2

1.3

7.53

7.18

mmol/l

1.89

529

3498

Adjustment and management of implanted device

597

0.85

0.51

1.1

1.2

8.17

7.82

mmol/l

0.30

502

Other disorders of bone

137

1246

1.10

0.51

1.3

7.18

7.10

mmol/l

0.12

122

1120

Drug-induced neutropenia

292

0.79

0.51

1.3

8.94

7.45

mmol/l

1.03

253

Ischaemic Stroke, excluding all haemorrhages

228

1825

0.93

0.51

1.3

1.2

7.74

7.70

mmol/l

0.05

194

1539

Peritonsillar abscess

169

1553

1.09

0.50

1.3

1.4

6.63

6.86

mmol/l

0.66

152

1403

COPD-related respiratory insufficiency

369

0.81

0.50

1.2

7.88

7.68

mmol/l

0.16

306

Bell's palsy

585

0.85

0.50

1.4

1.3

7.32

7.22

mmol/l

0.10

519

All dysplastic lesions of the cervix uteri

229

2437

0.93

0.50

1.5

6.93

6.64

mmol/l

0.78

217

2231

Schizophrenia or delusion, excluding more controls

223

2053

1.08

0.50

1.3

1.4

8.11

6.96

mmol/l

6.23

206

1835

Other and unspecified glaucoma

213

0.75

0.50

1.1

1.2

8.92

7.71

mmol/l

0.75

179

Myasthenia gravis

1.50

0.50

1.3

6.96

7.41

mmol/l

—

Voice disturbances

134

1471

0.91

0.50

1.3

7.05

7.34

mmol/l

0.67

122

1307

Conduction disorders

122

1091

0.91

0.49

1.2

7.94

7.53

mmol/l

0.63

114

914

Used for control exclusion in common control thyroid runs

895

4358

1.04

0.49

1.4

7.26

6.95

mmol/l

2.28

798

3885

Kyphosis

1.53

0.48

1.3

1.2

8.00

7.35

mmol/l

—

Asthma and allergy, excluding more controls

113

1008

1.11

0.48

1.5

1.4

6.29

6.62

mmol/l

0.72

106

898

Poisoning by drugs, medicaments and biological substances

161

1749

0.92

0.48

1.3

1.4

7.14

6.84

mmol/l

0.72

150

1575

Paroxysmal tachycardia

143

1094

1.09

0.48

1.2

1.3

7.29

7.00

mmol/l

0.57

124

961

Iron deficiency anaemia

216

2284

0.93

0.48

1.3

7.20

7.31

mmol/l

0.23

188

1990

Exophthalmic conditions

1.50

0.48

1.4

1.3

6.71

7.34

mmol/l

—

Melanoma in situ of trunk

1.50

0.47

1.4

1.2

8.23

7.47

mmol/l

—

Motor disorders

1.49

0.47

1.3

1.7

8.41

7.00

mmol/l

—

Other noninflammatory disorders of vulva and perineum

635

1.14

0.47

1.4

1.5

6.28

6.71

mmol/l

1.06

574

Aggressive periodontitis

1.42

0.47

1.6

1.3

8.32

7.45

mmol/l

0.44

Biological medication for rheuma

103

1141

0.90

0.47

1.4

7.10

6.96

mmol/l

0.17

1036

Polycystic ovarian syndrome, consortium definition

642

3649

1.04

0.46

1.4

7.15

6.76

mmol/l

3.30

596

3276

Other puerperal infections

768

1.12

0.46

1.8

1.6

6.54

6.57

mmol/l

0.03

708

Corneal ulcer

1077

0.90

0.46

1.4

1.3

7.05

7.10

mmol/l

0.07

972

Any mental disorder

846

4389

0.96

0.46

1.3

7.29

7.02

mmol/l

1.90

761

3877

Pedal cyclist injured in other and unspecified transport accidents

590

0.86

0.46

1.4

6.91

7.09

mmol/l

0.16

530

Specific developmental disorder of motor function

1.43

0.46

1.3

1.6

8.41

6.98

mmol/l

—

Periodontal disease, other/unspecified

129

1.32

0.46

1.1

1.4

6.30

7.27

mmol/l

0.86

114

Use of ropinirole

118

0.68

0.46

1.4

1.2

7.72

7.49

mmol/l

—

100

Gender identity disorders

0.59

0.46

1.2

1.8

6.80

6.82

mmol/l

—

Hypotension

547

0.86

0.45

1.2

7.82

7.80

mmol/l

0.01

445

Habit and impulse disorders

0.59

0.45

1.8

1.4

7.28

7.46

mmol/l

—

Melanocytic naevi, other sites/unspecified

421

1.17

0.45

1.3

6.88

7.22

mmol/l

0.44

377

Cystic kidney disease

121

0.66

0.45

1.5

1.4

7.20

7.24

mmol/l

—

104

Foreign body on external eye

779

1.12

0.45

1.2

1.3

7.66

7.18

mmol/l

0.85

693

DVT of lower extremities and pulmonary embolism

184

1972

0.93

0.45

1.3

1.2

7.91

7.48

mmol/l

1.02

160

1698

Type 2 diabetes, wide definition

455

2777

1.05

0.44

1.3

1.2

9.99

6.59

mmol/l

47.65

388

2427

Alcohol withdrawal state with delirium

275

0.80

0.44

1.1

1.2

8.67

7.43

mmol/l

0.94

237

Other bacterial intestinal infections

113

1241

0.91

0.44

1.3

7.07

7.26

mmol/l

0.36

103

1095

Malignant neoplasm of stomach, including Hilmo

186

0.75

0.44

1.2

7.51

7.98

mmol/l

0.21

154

Isolated proteinuria with specified morphological lesion

1.38

0.44

1.4

1.3

7.36

7.34

mmol/l

—

Diffuse brain injury

152

0.72

0.44

1.2

1.3

7.96

7.00

mmol/l

0.37

137

Benign neoplasm: Transverse colon

416

0.84

0.44

1.2

1.3

8.02

7.56

mmol/l

0.34

358

Gastroduodenal ulcer

986

0.90

0.44

1.2

8.30

7.75

mmol/l

0.68

836

Superficial injury of lower leg

170

1576

1.08

0.44

1.4

6.92

7.02

mmol/l

0.19

154

1403

Other diseases of anus and rectum

162

1496

1.08

0.43

1.2

1.3

7.35

7.48

mmol/l

0.25

139

1301

Barrett oesophagus

193

1.25

0.43

1.2

7.10

7.46

mmol/l

0.23

165

Endometriosis diagnosis and infertility diagnosis occurring together

839

1.11

0.43

1.4

6.77

6.79

mmol/l

0.04

758

Defects in the complement system

1.62

0.43

1.0

1.5

6.04

7.13

mmol/l

—

Malignant melanoma

597

0.87

0.43

1.2

7.26

7.59

mmol/l

0.36

506

Acute pancreatitis

893

0.89

0.43

1.3

1.2

8.11

7.49

mmol/l

0.93

786

Melanocytic naevi

185

1985

0.93

0.42

1.4

6.81

7.03

mmol/l

0.59

163

1785

Hidradenitis suppurativa

230

1.22

0.42

1.2

1.4

7.22

7.10

mmol/l

0.08

209

Common variable immunodeficiency

1.57

0.42

1.2

4.66

7.97

mmol/l

—

Seminoma of testis

1.57

0.42

1.0

1.1

9.18

7.82

mmol/l

—

Other skin changes

821

1.11

0.42

1.4

1.3

7.44

7.47

mmol/l

0.03

716

Fracture of skull and facial bones

113

1237

0.91

0.42

1.2

1.3

7.69

7.20

mmol/l

0.73

1107

Benign neoplasm: Rectum

707

1.12

0.42

1.1

1.2

7.55

7.73

mmol/l

0.15

612

Persistent mood disorders

111

1216

0.91

0.42

1.3

1.4

7.30

7.01

mmol/l

0.55

103

1079

Injury, poisoning and certain other consequences of external causes

499

2393

1.05

0.42

1.4

7.04

6.93

mmol/l

0.38

449

2129

Benign neoplasm: Sigmoid colon

765

0.89

0.42

1.1

1.2

6.83

7.76

mmol/l

1.93

657

Hypokalaemia

462

1.15

0.42

1.3

8.40

7.43

mmol/l

1.54

402

Wet age-related macular degeneration

457

1.15

0.42

1.2

8.68

8.03

mmol/l

0.53

355

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

139

0.72

0.42

1.9

1.3

6.60

7.27

mmol/l

—

119

Chondropathies

100

908

1.10

0.41

1.3

1.4

7.13

7.09

mmol/l

0.06

819

Gout, FINNGEN

118

1077

1.09

0.41

1.2

8.45

7.74

mmol/l

1.66

102

896

Implicit fungal Sepsis

294

0.81

0.41

1.3

7.31

7.56

mmol/l

0.23

251

Chronic periodontitis, complicated

318

2990

1.05

0.41

1.3

1.2

7.77

7.43

mmol/l

0.95

266

2616

Heart failure and coronary heart disease

145

1112

0.92

0.41

1.2

8.39

7.83

mmol/l

1.18

129

927

Malignant neoplasm of anus and anal canal

0.00

0.41

0.0

1.3

—

7.05

—

ILD, hospital admissions 1, main diag only

463

1.15

0.41

1.2

7.25

7.64

mmol/l

0.55

387

Synovial hypertrophy, not elsewhere classified

1.36

0.41

1.1

1.5

5.63

7.32

mmol/l

—

Thyroiditis

379

1.16

0.41

1.4

6.24

7.13

mmol/l

1.64

336

Degeneration of macula and posterior pole

170

1454

0.93

0.41

1.1

1.2

7.67

7.88

mmol/l

0.36

152

1208

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.41

0.0

1.2

—

7.41

—

Malaise and fatigue

295

2506

0.95

0.41

1.3

7.06

7.19

mmol/l

0.33

253

2186

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

0.00

0.41

0.0

1.1

—

7.49

—

Acute appendicitis, with complications

1067

0.91

0.41

1.1

1.3

7.83

7.27

mmol/l

0.87

953

Shoulder region

1.34

0.40

1.4

1.3

6.00

7.31

mmol/l

—

Ulcerative colitis, NAS

804

0.89

0.40

1.4

7.34

7.05

mmol/l

0.40

726

Mucinous and mucinous cystic tumor of rectum

0.00

0.40

0.0

1.1

—

7.55

—

Disorders of purine and pyrimidine metabolism

0.00

0.40

0.0

1.2

—

7.88

—

Disorders of parathyroid gland

825

0.90

0.40

1.2

7.79

7.61

mmol/l

0.17

710

Benign neoplasm: Ascending colon

521

1.13

0.40

1.2

7.93

7.66

mmol/l

0.28

447

Disorders of calcium metabolism

232

1.21

0.40

1.2

1.3

7.56

7.41

mmol/l

0.13

206

Cardiac murmurs and other cardiac sounds

516

1.13

0.39

1.4

1.5

6.99

6.86

mmol/l

0.16

466

Neoplasms

692

3795

0.97

0.39

1.4

6.95

6.88

mmol/l

0.26

625

3418

Erosion and ectropion of cervix uteri

124

1.29

0.38

1.6

1.4

6.53

7.12

mmol/l

0.46

111

Hallux rigidus

598

1.12

0.38

1.2

7.45

7.64

mmol/l

0.23

519

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.37

0.38

1.3

7.19

7.59

mmol/l

—

D07AA Corticosteroids, weak (group I)

1040

0.91

0.38

1.6

1.4

6.70

6.85

mmol/l

0.26

951

Hypertrophy of breast in women and men

134

1240

1.08

0.38

1.3

7.00

7.05

mmol/l

0.09

129

1113

Crohn disease

769

0.90

0.38

1.4

7.23

6.98

mmol/l

0.29

695

Viral Sepsis

968

0.91

0.38

1.3

7.60

7.42

mmol/l

0.23

840

Atrial fibrillation and flutter with reimbursement

133

781

1.08

0.38

1.2

1.1

8.17

7.23

mmol/l

2.91

118

664

Early lumbar disc prolapse operation

761

1.11

0.38

1.3

1.4

6.88

6.99

mmol/l

0.10

706

Assault by blunt object

1.33

0.37

1.2

1.3

8.82

7.47

mmol/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

666

1.11

0.37

1.2

7.62

7.52

mmol/l

0.09

567

Other infectious diseases

392

1.15

0.37

1.2

1.3

7.46

7.30

mmol/l

0.11

343

Postpartum hemorraghe, parous women as controls

327

2653

1.05

0.37

1.6

1.5

6.32

6.48

mmol/l

0.95

309

2424

Hyperkinetic disorders (excl. ADHD)

1.31

0.37

1.4

1.6

7.85

7.18

mmol/l

—

Benign neoplasm: Rectum, anus and anal canal

819

1.10

0.37

1.1

1.2

7.41

7.75

mmol/l

0.38

710

GASTRO-related operations

762

3700

1.03

0.37

1.4

7.02

6.88

mmol/l

0.68

695

3289

Any gastric operation

762

3700

1.03

0.37

1.4

7.02

6.88

mmol/l

0.68

695

3289

conjunctival haemorrhage

271

1.18

0.37

1.2

1.3

7.80

7.48

mmol/l

0.12

232

Benign neoplasm: Spinal meninges

1.36

0.37

1.2

10.86

7.47

mmol/l

—

Benign mammary dysplasia

673

0.89

0.37

1.3

6.63

7.43

mmol/l

2.22

576

Enterobiasis

143

1.26

0.37

1.5

1.6

6.87

6.95

mmol/l

0.05

127

Other and unspecified polyneuropathies, also in other diseases

757

0.90

0.37

1.4

1.2

7.47

7.76

mmol/l

0.35

648

Schizophrenia

877

1.10

0.37

1.3

8.52

7.04

mmol/l

3.63

792

Erosion of teeth , including avohilmo

168

1795

0.94

0.37

1.4

6.72

6.85

mmol/l

0.33

153

1625

Other and unspecified coagulation defects

281

1.18

0.36

1.4

6.68

7.10

mmol/l

0.43

251

Other bacterial intestinal infections

850

0.91

0.36

1.2

1.3

7.13

7.39

mmol/l

0.41

744

Complications of surgical and medical care, not elsewhere classified

697

4927

0.97

0.36

1.3

7.25

7.08

mmol/l

0.93

632

4354

Congenital malformations of heart and great arteries

629

1.11

0.36

1.2

1.4

6.82

7.02

mmol/l

0.22

569

Injuries to unspecified part of trunk, limb or body region

469

1.13

0.36

1.1

1.3

7.16

7.21

mmol/l

0.04

411

Hyperprolactinaemia

234

0.81

0.36

1.3

1.4

6.64

7.02

mmol/l

0.55

210

Skin changes due to chronic exposure to nonionizing radiation

143

1227

1.08

0.36

1.2

7.44

7.96

mmol/l

1.11

115

1016

Implicit viral Sepsis

964

0.91

0.35

1.3

7.60

7.39

mmol/l

0.27

836

Diarrhoea and gastroenteritis of presumed infectious origin

498

4653

0.96

0.35

1.3

1.4

7.21

7.01

mmol/l

0.90

445

4131

Behavioural disorders

122

0.74

0.35

1.2

1.6

8.22

6.99

mmol/l

—

109

Other diseases of urinary system

772

4471

0.97

0.35

1.4

7.03

6.99

mmol/l

0.14

705

3968

Other and unspecified disease of Bartholin gland

122

0.74

0.35

1.3

1.4

7.52

7.55

mmol/l

—

100

Pain associated with micturition

555

1.12

0.35

1.2

1.3

6.75

7.25

mmol/l

0.75

493

Pain, not elsewhere classified

193

1817

1.06

0.35

1.4

1.3

7.24

7.04

mmol/l

0.45

171

1613

Other facial nerve disorders

124

0.72

0.35

1.3

6.98

7.40

mmol/l

—

106

Conjunctivitis (acute, non atopic)

178

1887

0.94

0.35

1.4

7.26

7.06

mmol/l

0.37

164

1693

Other noninflammatory disorders of vagina

470

1.13

0.35

1.5

7.01

6.93

mmol/l

0.08

424

Benign neoplasm: Vagina

1.40

0.35

1.2

1.4

8.07

7.22

mmol/l

—

Other gastritis (incl. Duodenitis)

114

1053

1.08

0.35

1.4

1.2

7.42

7.51

mmol/l

0.13

104

912

Other disorders of patella

126

1169

1.08

0.35

1.3

7.14

7.08

mmol/l

0.09

115

1048

L02BG Aromatase inhibitors

134

1437

0.93

0.35

1.3

7.43

7.46

mmol/l

0.04

123

1245

157

1346

1.07

0.34

1.2

7.34

7.89

mmol/l

1.32

127

1122

Dislocation, sprain and strain of joints and ligaments at neck level

114

1054

1.08

0.34

1.5

1.4

6.65

6.86

mmol/l

0.49

104

959

Palindromic rheumatism

1.37

0.34

1.3

1.5

7.31

7.04

mmol/l

—

Other metabolic disorders

766

1.10

0.34

1.3

1.4

7.17

7.07

mmol/l

0.13

690

Atopic dermatitis, strict definition with reimbursement

274

2518

1.05

0.34

1.5

1.4

6.71

6.69

mmol/l

0.05

255

2296

Congenital malformations and deformations of the musculoskeletal system

525

1.12

0.34

1.4

1.5

6.88

6.82

mmol/l

0.06

480

Syncope and collapse

253

2279

0.95

0.34

1.3

7.15

7.22

mmol/l

0.14

225

1979

Poisoning by medicine

147

1572

0.93

0.34

1.3

1.4

7.20

6.84

mmol/l

0.90

136

1428

Allergic rhinitis

229

2387

0.95

0.34

1.4

6.63

6.84

mmol/l

0.60

210

2150

Diseases of salivary glands

207

1957

1.06

0.34

1.4

1.3

7.23

7.19

mmol/l

0.06

190

1737

Other and unspecified drugs and medicaments

396

1.14

0.33

1.4

1.3

7.14

7.25

mmol/l

0.08

352

Ventricular septal defect, a heart condition

1.34

0.33

1.4

1.6

6.17

7.17

mmol/l

1.26

Sequelae of external causes of morbidity and mortality

123

1323

0.93

0.33

1.4

1.3

7.48

7.39

mmol/l

0.12

113

1159

Dermatitis due to substances taken internally

275

0.83

0.33

1.1

1.4

6.49

7.30

mmol/l

1.28

247

Malignant neoplasm of stomach

155

0.77

0.33

1.3

1.2

7.35

7.92

mmol/l

0.23

126

Other immunodeficiencies

1.31

0.33

1.2

1.5

5.67

7.07

mmol/l

—

Fourth [trochlear] nerve palsy

0.70

0.33

1.0

1.3

6.17

7.10

mmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

447

4415

0.96

0.33

1.4

7.06

6.90

mmol/l

0.60

407

3987

Childhood allergy (age < 16)

155

1197

1.07

0.33

1.8

1.6

6.18

6.30

mmol/l

0.38

147

1100

Prurigo nodularis

0.68

0.33

1.2

1.3

6.94

7.54

mmol/l

—

Endometriosis ASRM stages 3,4

149

1590

0.94

0.33

1.3

1.4

7.17

6.97

mmol/l

0.40

129

1425

Use of biperiden

219

1.19

0.33

1.3

9.05

7.36

mmol/l

1.77

195

Viral infections characterized by skin and mucous membrane lesions

616

5431

0.97

0.33

1.3

1.4

7.06

7.02

mmol/l

0.12

552

4827

Symptoms and signs involving the urinary system

469

3444

1.04

0.33

1.3

7.44

7.28

mmol/l

0.54

419

2998

Abnormal findings on diagnostic imaging of central nervous system

247

1.18

0.33

1.3

1.4

6.69

7.23

mmol/l

0.67

215

Excessive, frequent and irregular menstruation

381

2003

1.04

0.32

1.4

1.5

6.92

6.62

mmol/l

1.61

345

1815

ILD, hospital admission 2, with pulmonary infections

328

0.85

0.32

1.2

7.73

7.44

mmol/l

0.21

263

Herpesviral [herpes simplex] infections

635

1.10

0.32

1.3

1.4

7.08

7.18

mmol/l

0.11

574

Burns and corrosions

760

0.91

0.32

1.4

6.79

7.04

mmol/l

0.30

685

Burns and corrosions of multiple body regions

1.28

0.32

1.0

1.4

6.12

7.62

mmol/l

—

Disorder of thyroid, unspecified

1.28

0.32

1.0

1.2

7.77

7.08

mmol/l

—

Primary open-angle glaucoma

119

1069

1.08

0.32

1.2

7.88

7.91

mmol/l

0.04

102

880

Ventral hernia

126

1174

1.07

0.32

1.4

1.2

7.38

7.51

mmol/l

0.18

112

1021

Bronchiectasis

266

1.17

0.32

1.5

1.3

7.21

7.56

mmol/l

0.26

218

Other secondary coxarthrosis

132

0.76

0.32

1.1

1.3

8.51

7.36

mmol/l

—

113

Disorders of eyelid, lacrimal system and orbit

588

4324

1.03

0.32

1.3

7.16

7.17

mmol/l

0.03

517

3823

Gastric ulcer

644

0.90

0.32

1.1

1.2

8.29

7.78

mmol/l

0.46

547

Primary open-angle glaucoma, strict

912

1.08

0.32

1.2

8.09

7.96

mmol/l

0.17

749

Other protozoal intestinal diseases

110

1.28

0.32

1.2

1.4

6.43

7.27

mmol/l

0.95

Noninfectious colitis NAS

696

0.90

0.31

1.3

7.66

7.10

mmol/l

0.67

625

Bacterial intestinal infections, IBD co-morbidities

842

0.91

0.31

1.2

1.3

7.13

7.42

mmol/l

0.47

738

Genitourinary diseases

485

2346

1.04

0.31

1.3

7.09

6.96

mmol/l

0.44

433

2072

Menorrhagia

274

1594

0.95

0.31

1.4

1.5

7.09

6.75

mmol/l

1.20

249

1433

Primary coxarthrosis, bilateral

121

1127

1.07

0.31

1.2

7.63

7.77

mmol/l

0.24

102

949

Other and unspecified local infections of skin and subcutaneous tissue

446

1.12

0.31

1.3

7.54

7.18

mmol/l

0.33

398

Benign neoplasms

836

4486

1.03

0.31

1.3

1.4

7.08

6.97

mmol/l

0.52

736

4028

Abnormal blood-pressure reading, without diagnosis

202

1.19

0.31

1.3

1.4

7.38

7.31

mmol/l

0.03

179

Urethritis and urethral syndrome

0.73

0.31

1.1

1.4

7.21

7.33

mmol/l

—

HSIL lesion of the cervix uteri

163

1728

0.94

0.30

1.5

7.01

6.61

mmol/l

0.93

155

1577

Psoriasis vulgaris

108

1004

1.08

0.30

1.3

7.77

7.21

mmol/l

1.07

897

Carcinoma in situ of skin

261

0.84

0.30

1.1

1.2

7.87

7.77

mmol/l

0.04

216

Sudden idiopathic hearing loss

419

1.12

0.30

1.3

7.79

7.35

mmol/l

0.46

371

Central retinal artery occlusion

1.28

0.30

1.0

1.2

7.86

7.62

mmol/l

—

Other specified/unspecified arthritis

164

1548

1.06

0.30

1.3

7.44

7.27

mmol/l

0.25

146

1372

Inflammatory diseases of female pelvic organs

527

3752

1.03

0.30

1.4

6.97

6.80

mmol/l

0.88

487

3379

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

348

3252

1.04

0.29

1.3

7.23

7.22

mmol/l

0.02

317

2865

Haemorrhoids and perianal venous thrombosis

171

1613

1.06

0.29

1.2

1.3

7.18

7.45

mmol/l

0.67

152

1400

Normotensive glaucoma

271

0.85

0.29

1.2

8.52

7.90

mmol/l

0.40

223

Disorders of eyelid in diseases classified elsewhere

148

1.22

0.29

1.2

1.3

6.61

7.30

mmol/l

0.69

129

Injuries to the abdomen, lower back, lumbar spine and pelvis

220

2283

0.95

0.29

1.4

1.3

7.21

7.17

mmol/l

0.07

202

2005

Early onset COPD, excluding more controls

992

0.93

0.29

1.4

1.2

7.52

7.37

mmol/l

0.17

845

Injury of muscle and tendon at lower leg level

754

0.91

0.29

1.1

1.2

7.70

7.31

mmol/l

0.49

672

Panic disorder

118

1261

0.93

0.29

1.4

1.5

6.83

6.65

mmol/l

0.35

113

1154

Cellulitis

111

1189

0.93

0.29

1.3

7.64

7.18

mmol/l

0.79

104

1060

Disorders of psychological development

699

0.91

0.29

1.4

1.6

7.30

6.55

mmol/l

1.50

638

Burns and corrosions of external body surface, specified by site

555

0.90

0.28

1.4

1.3

6.57

7.01

mmol/l

0.90

499

Acute appendicitis, no complications

430

4139

1.03

0.28

1.4

1.3

7.10

6.99

mmol/l

0.36

392

3712

Ulcer of oesophagus

259

0.85

0.28

1.1

1.3

8.00

7.50

mmol/l

0.25

221

Burns and corrosions of multiple and unspecified body regions

1.28

0.28

1.3

1.4

8.06

7.57

mmol/l

0.11

Benign neoplasm of eye and adnexa

431

1.12

0.28

1.2

1.3

6.88

7.50

mmol/l

0.95

375

Coronary artery bypass grafting

654

0.92

0.28

1.1

1.2

8.72

7.94

mmol/l

1.06

536

Dermatitis

416

4008

1.03

0.27

1.3

7.05

7.15

mmol/l

0.32

355

3553

Anxiety disorders, excluding more controls

673

4262

1.03

0.27

1.4

1.3

7.09

6.97

mmol/l

0.53

612

3779

Complications of internal orthopaedic prosthetic devices, implants and grafts

912

1.08

0.27

1.3

1.2

7.65

7.74

mmol/l

0.12

779

Conduct disorder

119

0.75

0.27

1.2

1.6

8.22

6.71

mmol/l

—

107

Dislocation, sprain and strain of joints and ligaments of knee

479

4279

1.03

0.27

1.3

7.08

6.98

mmol/l

0.30

438

3833

Otitis media, unspecified

689

1.08

0.27

1.6

1.5

6.69

mmol/l

0.01

625

Non-selective monoamine reuptake inhibitors

214

1968

1.05

0.27

1.3

7.54

7.42

mmol/l

0.26

186

1714

Nonorganic sleeping disorders, excluding more controls

139

1473

0.94

0.27

1.4

7.22

6.75

mmol/l

1.03

128

1330

Other lack of coordination

1.21

0.27

1.6

1.3

7.29

7.69

mmol/l

—

Idiopathic urticaria

113

1.24

0.26

1.1

1.4

7.06

7.23

mmol/l

0.10

Cyst of kidney

262

1.15

0.26

1.3

7.16

7.59

mmol/l

0.28

225

Hypertrophy of breast

122

1147

1.06

0.26

1.3

1.4

7.03

7.01

mmol/l

0.03

117

1028

Other systemic involvement of connective tissue (FG)

147

1372

1.06

0.26

1.3

7.24

7.30

mmol/l

0.09

137

1207

Vasomotor and allergic rhinitis

300

2834

1.04

0.26

1.4

6.77

6.92

mmol/l

0.42

275

2557

LSIL lesion of the cervix uteri, vagina or vulva

107

1142

0.94

0.26

1.4

1.5

7.03

6.76

mmol/l

0.50

100

1035

Noninflammatory disorders of female genital tract

417

2024

1.03

0.26

1.5

6.95

6.61

mmol/l

1.63

373

1833

Postmenopausal atrophic vaginitis

135

701

1.06

0.26

1.2

6.90

7.45

mmol/l

1.63

118

608

Separation of retinal layers (serosa)

178

1.18

0.26

1.4

1.3

8.74

7.31

mmol/l

0.45

156

Wegener granulomatosis

0.69

0.26

1.0

1.3

7.64

7.28

mmol/l

—

Polyarthrosis

768

1.08

0.26

1.2

8.63

7.66

mmol/l

1.46

661

Malignant cancer of tonsil and base of tongue

0.70

0.26

1.0

1.2

8.10

7.70

mmol/l

—

Malignant neoplasm of oropharynx, including Hilmo

0.68

0.26

1.0

1.2

8.10

7.56

mmol/l

—

Disorders of oesophagus in diseases classified elsewhere

0.68

0.26

1.0

1.2

6.18

8.15

mmol/l

—

Oxicams

146

783

1.06

0.26

1.2

1.4

7.20

7.11

mmol/l

0.12

126

663

Benign neoplasm: Skin of eyelid, including canthus

664

1.09

0.26

1.2

7.13

7.52

mmol/l

0.57

580

Vitamin B12 deficiency anaemia

373

0.88

0.26

1.3

7.29

7.68

mmol/l

0.25

315

Benign neoplasm: Caecum

394

0.89

0.26

1.1

1.3

7.40

7.61

mmol/l

0.16

332

Other local infections of skin and subcutaneous tissue

472

1.10

0.26

1.3

7.54

7.18

mmol/l

0.34

417

Other congenital malformations

510

1.10

0.26

1.7

1.5

7.03

6.89

mmol/l

0.15

462

Adenocarcinoma and papillary adenocarcinoma of stomach

0.67

0.26

1.4

1.2

7.10

7.85

mmol/l

—

Deep bite

506

1.09

0.25

1.4

6.61

7.00

mmol/l

0.75

456

Other disorders of bone density and structure

132

1.22

0.25

1.6

1.3

6.72

7.49

mmol/l

0.59

113

Fenamates

103

747

0.93

0.25

1.3

1.4

6.87

6.79

mmol/l

0.14

654

Unspecified jaundice

149

0.80

0.25

1.0

1.2

7.28

7.39

mmol/l

0.05

130

Sarcoidosis

597

1.09

0.25

1.2

7.34

7.48

mmol/l

0.17

528

Osteopathies and chondropathies

312

3013

0.96

0.25

1.3

7.12

7.28

mmol/l

0.49

279

2649

Diplopia

613

0.91

0.25

1.4

1.3

7.82

7.32

mmol/l

0.46

540

Seborrhoeic dermatitis

425

0.89

0.25

1.2

1.3

7.83

7.41

mmol/l

0.28

380

Congenital malformations, deformations and chromosomal abnormalities

494

4681

0.97

0.25

1.4

7.01

6.92

mmol/l

0.32

448

4216

Hypersomnia

1.22

0.25

1.6

1.4

6.02

7.18

mmol/l

—

Sexual dysfunction

1.22

0.25

1.4

6.84

7.61

mmol/l

—

Adhesive middle ear disease

1.22

0.25

1.8

1.5

7.52

7.13

mmol/l

—

ILD, hospital admissions

521

1.09

0.25

1.2

7.32

7.66

mmol/l

0.43

438

Melanocytic naevi of other and unspecified parts of face

311

1.13

0.25

1.5

1.4

6.87

7.18

mmol/l

0.29

276

Congenital malformations of the respiratory system

1.20

0.25

1.3

5.37

7.35

mmol/l

—

Chronic suppurative otitis media, including avohilmo

349

1.12

0.25

1.2

1.4

6.65

7.08

mmol/l

0.69

310

Synovial cyst of popliteal space [Baker]

283

1.13

0.24

1.4

1.3

6.31

7.67

mmol/l

2.37

241

Postprocedural endocrine and metabolic disorders, not elsewhere classified

705

1.08

0.24

1.3

1.4

7.10

7.08

mmol/l

0.02

636

Tumor necrosis factor alpha inhibitors

1035

0.94

0.24

1.5

1.4

7.20

6.95

mmol/l

0.31

938

Mixed specific developmental disorders

1.17

0.24

1.4

1.7

7.99

6.95

mmol/l

—

Ectopic pregnancy

125

1181

1.06

0.24

1.6

1.3

6.87

7.01

mmol/l

0.23

114

1073

Other and unspecified acute skin changes due to ultraviolet radiation

1.29

0.24

1.1

1.2

7.63

7.44

mmol/l

—

Viral pneumonia

642

0.92

0.24

1.4

1.3

6.82

7.26

mmol/l

0.72

560

Malignant cancer of tonsil and base of tongue, including Hilmo

0.73

0.24

1.0

1.2

7.80

7.66

mmol/l

—

Foreign body entering into or through eye or natural orifice

369

1.11

0.24

1.4

1.3

7.27

7.03

mmol/l

0.21

329

Epilepsy

171

1625

1.05

0.24

1.2

1.3

7.22

7.24

mmol/l

0.04

155

1440

Cleft lip, lip and palate or palate

0.71

0.24

1.3

1.5

6.12

7.43

mmol/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.71

0.24

1.2

1.3

8.13

7.18

mmol/l

—

Other localized connective tissue disorders

0.71

0.24

1.2

1.4

6.96

7.23

mmol/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS